Skip to main content
eLife logoLink to eLife
. 2018 Dec 14;7:e42955. doi: 10.7554/eLife.42955

Genetic analysis reveals functions of atypical polyubiquitin chains

Fernando Meza Gutierrez 1,, Deniz Simsek 2,, Arda Mizrak 1, Adam Deutschbauer 3, Hannes Braberg 4, Jeffrey Johnson 4, Jiewei Xu 4, Michael Shales 4, Michelle Nguyen 5, Raquel Tamse-Kuehn 5, Curt Palm 5, Lars M Steinmetz 5, Nevan J Krogan 4, David P Toczyski 1,
Editors: Michael Rape6, Ivan Dikic7
PMCID: PMC6305200  PMID: 30547882

Abstract

Although polyubiquitin chains linked through all lysines of ubiquitin exist, specific functions are well-established only for lysine-48 and lysine-63 linkages in Saccharomyces cerevisiae. To uncover pathways regulated by distinct linkages, genetic interactions between a gene deletion library and a panel of lysine-to-arginine ubiquitin mutants were systematically identified. The K11R mutant had strong genetic interactions with threonine biosynthetic genes. Consistently, we found that K11R mutants import threonine poorly. The K11R mutant also exhibited a strong genetic interaction with a subunit of the anaphase-promoting complex (APC), suggesting a role in cell cycle regulation. K11-linkages are important for vertebrate APC function, but this was not previously described in yeast. We show that the yeast APC also modifies substrates with K11-linkages in vitro, and that those chains contribute to normal APC-substrate turnover in vivo. This study reveals comprehensive genetic interactomes of polyubiquitin chains and characterizes the role of K11-chains in two biological pathways.

Research organism: S. cerevisiae

Introduction

The ubiquitination of proteins is a highly conserved posttranslational modification that can alter the stability, localization, and function of proteins (Finley et al., 2012). Ubiquitination regulates a broad range of important cellular pathways including the DNA damage response (Jackson and Durocher, 2013; Harper and Elledge, 2007), apoptosis (Broemer and Meier, 2009), cell cycle progression (Borg and Dixit, 2017), immune and inflammatory responses (Wertz and Dixit, 2010), and transcription (Geng et al., 2012). Three enzyme classes mediate the covalent attachment of ubiquitin, a 76 amino acid protein, to target proteins: An E1 ubiquitin-activating enzyme activates ubiquitin for transfer to an E2 ubiquitin-conjugating enzyme, which in turn interacts with an E3 ubiquitin ligase to transfer ubiquitin to lysine residues on the target protein (Hershko and Ciechanover, 1998). This enzymatic cascade can also transfer ubiquitin onto lysine residues of ubiquitin itself, thereby generating chains of polyubiquitin on target proteins (Hershko and Ciechanover, 1998).

Ubiquitin has seven acceptor lysines (K6, K11, K27 K29, K33, K48, and K63), all of which are used in vivo to generate polyubiquitin chains (Xu et al., 2009). Polyubiquitin can also be linked through the N-terminal amino group of methionine one in ubiquitin, termed linear ubiquitin chains, although to our knowledge, this has not been documented in S. cerevisiae. K48 and K11 are the most abundant ubiquitin linkage types—each accounting for about a third of ubiquitin linkages in yeast—while the remaining five are present in relatively lower amounts (Xu et al., 2009). Ubiquitin chains vary in their three-dimensional conformations. K48-linked chains, for example, adopt a closed conformation with ubiquitin’s hydrophobic patch being sequestered at the interface between two adjacent ubiquitin protomers (Komander and Rape, 2012). In contrast, K63-linked chains assume an extended conformation devoid of non-covalent contacts between ubiquitin monomers (Datta et al., 2009).

The structural diversity of polyubiquitin chains gives rise to disparate fates for protein targets (Komander and Rape, 2012). K48-linked chains, for example, specify proteins for proteasomal degradation (Chau et al., 1989), while K63-linked chains have non-degradative roles in various signaling pathways including the DNA damage response (Harper and Elledge, 2007; Xu et al., 2009; Ulrich, 2005; Spence et al., 1995; Wang and Elledge, 2007), protein trafficking (Lauwers et al., 2009; MacGurn et al., 2012), mitophagy (Ordureau et al., 2015), inflammation (Deng et al., 2000; Grabbe et al., 2011; Wang et al., 2001), and immune responses (Manzanillo et al., 2013). Degradative functions of K11 linkages in endoplasmic reticulum biology as well as Hedgehog signaling in fruit flies have been described (Xu et al., 2009; Zhang et al., 2013), while the critical role of K11-linkages in mitotic progression in metazoans has been studied in detail (Meyer and Rape, 2014; Williamson et al., 2009; Matsumoto et al., 2010; Wu et al., 2010; Jin et al., 2008; Yau et al., 2017). Although K6, K27, K29, and K33 ubiquitin linkages are especially rare in cells (Xu et al., 2009; Dammer et al., 2011), important observations have contributed to an increasing recognition of their physiological relevance (Akutsu et al., 2016). K6-linked polyubiquitin chains, for example, are reported to function in the DNA damage response through the BRCA1-BARD1 E3 ligase in a proteolysis-independent manner, as well as in mitophagy, through the E3 ligase, Parkin (Ordureau et al., 2015; Nishikawa et al., 2004; Christensen et al., 2007; Ordureau et al., 2014). K27-linkages have also been linked to mitophagy, as some Parkin substrates are reportedly decorated with K27-linked ubiquitin chains (Birsa et al., 2014; Geisler et al., 2010). mRNA stability is regulated by K29-linked ubiquitin chains on HuR, an mRNA binding protein, via an interaction with UBXD8, an adaptor for the essential p97 ATPase (Zhou et al., 2013). Finally, K33-linked ubiquitin chains have been suggested to regulate post-Golgi protein trafficking by mediating the interaction of Coronin-7 with Eps15, a trans-golgi network protein (Yuan et al., 2014).

Notwithstanding these and other intriguing observations (Silva et al., 2015; Song et al., 2010; Elia et al., 2015), a comprehensive examination of the roles of K6, K11, K27, K29, and K33 ubiquitin linkages is lacking, particularly in yeast. This is owed to both the partial redundancy of ubiquitin acceptor lysines (Xu et al., 2009), and the technical limitations of current protein analysis methods (Swatek and Komander, 2016; Carrano and Bennett, 2013). A high-throughput approach to uncover physiologically important functions of specific ubiquitin linkage types would significantly advance current understanding of the ubiquitin-proteasome system. Genetic interaction analysis, namely the study of the phenotypic effects of combining mutations, has long been a powerful tool for discovering novel gene-functions by revealing functional relationships between genes (Dixon et al., 2009; Tong et al., 2001; Tong et al., 2004; Schuldiner et al., 2005; Braberg et al., 2013; Costanzo et al., 2010; Costanzo et al., 2016; Sarin et al., 2004).

This report describes a comprehensive genetic analysis to uncover pathways that are regulated by specific ubiquitin linkage types. In a high-throughput manner, single deletions of non-essential genes were combined with mutations eliminating specific ubiquitin linkages. The growth phenotypes of double mutant strains were quantified to identify thousands of candidate genetic interactions. The genetic interactome of K11 linkages was of special interest due to that linkage type’s relatively high abundance in yeast (Xu et al., 2009), and its known functions in the metazoan cell cycle (Meyer and Rape, 2014). Our genetic, molecular and biochemical analysis led us to the discovery of novel physiological functions of K11 linkages in promoting amino acid import and contributing to cell cycle progression. Our data are consistent with a model whereby the human and yeast APC both use K48 and K11 linkages to attain maximal efficiency, but they do so in a reciprocal fashion; in humans, K48 is part of a base chain from which homogenous K11-linked chains are extended, whereas in yeast, K11 is the critical linkage for a base chain, from which homogenous K48 chains are extended.

Results

The ubiquitin linkage synthetic genetic array

A synthetic genetic array analysis (SGA) was undertaken to identify pathways that are regulated by specific polyubiquitin chain types (Tong et al., 2004). Yeast strains constitutively expressing single, double, and triple lysine-to-arginine (K-to-R) mutant ubiquitin alleles were engineered by modifying all four loci from which ubiquitin is normally expressed in yeast (Finley et al., 2012) (Figure 1A, Materials and methods, Figure 1—figure supplement 1). The engineered yeast strains express ubiquitin at levels comparable to wild-type yeast (Figure 1—figure supplement 2). A strain expressing low levels of wild-type ubiquitin (lacking ubiquitin expression at the modified ubi4 locus) was also included in the ubiquitin SGA to control for possible non-specific effects of perturbing ubiquitin levels (Figure 1—figure supplement 2, Figure 1—figure supplement 3A, Materials and methods). Because lysine 48 of ubiquitin is essential (Finley et al., 1994), strains expressing K48R ubiquitin also contained 20% wild-type ubiquitin (Figure 1—figure supplement 3B, Materials and methods). K63R ubiquitin mutants were initially included, but analysis of the data was not possible due to their extreme hypersensitivity to canavanine (data not shown), a toxic arginine analog used in the SGA protocol, even in the context of the deletion of the CAN1 sensitivity gene (Figure 1—figure supplement 4). Linear ubiquitin chains were not analyzed in this study. The lysine-to-arginine ubiquitin mutant strains were systematically mated to a gene deletion library. The resulting diploid cells underwent sporulation to generate haploid double mutant cells expressing mutant ubiquitin alleles and carrying single gene deletions (Figure 1—figure supplement 4). Colony sizes of the approximately forty-five thousand pairwise combinations were measured to identify genetic interactions.

Figure 1. The ubiquitin linkage SGA reveals the genetic interactome of polyubiquitin chain types and functional relationships between lysines of ubiquitin.

(A) UBI1-UBI4 were modified to express lysine to arginine mutant ubiquitin alleles under the control of the constitutive GPD promoter. Ribosomal proteins, which are normally encoded at UBI1-UBI3, were also placed under the control of the GPD promoter individually, or as ubiquitin-fusions. (B) Top: A clustered heat map of quantitative genetic interactions between ubiquitin K-to-R mutants and an array of single gene deletions. Each K-to-R is expressed as the only ubiquitin present in the cell, except for K48R, which is lethal and was therefore co-expressed with WT ubiquitin (20% of total). As indicated in the adjacent color legend, blue pixels represent negative genetic interaction scores, yellow pixels represent positive genetic interaction scores, and black pixels indicate no interaction. Grey pixels represent interactions displaying extremely low signal, which could represent either strong negative interactions or pinning errors. Bottom: Unbiased hierarchical clustering identifies known gene modules. Named genes are part of the complexes or pathways listed (bold), or have related functions. (C) Scatter plot comparing the genetic interaction scores in two biological replicates of the ubiquitin SGA. The correlation coefficient between the two replicates was calculated. (D) The correlation of genetic interaction profiles of physically interacting or non-interacting gene pairs in the ubiquitin SGA and the chromosome biology E-MAP (Collins et al., 2007). (E) The correlation between the genetic interactomes of K-to-R ubiquitin mutants is shown as a heat map of correlation coefficients, and a dendogram showing hierarchical clustering. As the color legend indicates, correlation coefficient values of 1 are shown as yellow pixels, while values of −1 are shown as blue pixels. (F) A histogram showing the frequencies (Log2) of genetic interactions with the indicated S-scores for each single K-to-R ubiquitin mutant.

Figure 1.

Figure 1—figure supplement 1. Engineering of ubi2-4 to express K-to-R mutant ubiquitin.

Figure 1—figure supplement 1.

(A) UBI2 was modified to express two copies of the ribosomal protein Rpl40A, each from a GPD promoter. The locus is marked with a hygromycin resistance cassette. (B) The engineered UBI3 locus is marked with a URA3 cassette and expresses three tandem copies of ubiquitin fused to the ribosomal protein Rps31, under the control of the GPD promoter. An additional copy of Rps31 is expressed from its own GPD promoter. (C) UBI4 was modified to carry two copies of the GPD promoter, each driving expression of mutant ubiquitin. The locus is marked with a nourseothricin (NAT) resistance cassette. (A–C) Asterisks indicate mutant ubiquitin alleles.
Figure 1—figure supplement 2. Analysis of ubiquitin levels in K-to-R ubiquitin mutants.

Figure 1—figure supplement 2.

The levels of ubiquitin were analyzed by western blotting. A wild-type SK1 strain with endogenous UBI1-4 was compared to the strains used in this study that express K-to-R mutant ubiquitin alleles, as well as wild-type ubiquitin, from engineered ubiquitin loci. PSTAIR was used as loading control.
Figure 1—figure supplement 3. Engineering of strains expressing low levels of ubiquitin, and K48R ubiquitin mutants.

Figure 1—figure supplement 3.

(A) A strain expressing ubiquitin at low levels was generated as described in Figure 1—figure supplement 1, with the notable difference that UBI4 locus was replaced only with the NAT resistance cassette. Ubiquitin is therefore only expressed from ubi3. (B) Strains expressing K48R ubiquitin were complemented with wild-type ubiquitin to permit viability. At ubi3, the first two ubiquitins are mutated at K48, while the third ubiquitin is wild type; at ubi4, K48R mutant ubiquitin is expressed. Asterisks indicate mutant ubiquitin alleles. Strains expressing ubiquitin with the K48R and another lysine mutation express one copy of double lysine mutant ubiquitin at ubi3 and two copies at ubi4.
Figure 1—figure supplement 4. The ubiquitin allele SGA protocol Ubiquitin K-to-R mutant strains were mated to an array of single-gene deletion strains.

Figure 1—figure supplement 4.

Several selection steps allowed for the generation of haploid, MATa strains carrying a single gene deletion and expressing K-to-R mutant ubiquitin. The colony sizes of each strain were recorded to identify genetic interactions. A detailed description of the ubiquitin allele protocol is included in the Materials and methods section.
Figure 1—figure supplement 5. Genetic modifications modestly increase the sporulation efficiency of the S288C yeast strain.

Figure 1—figure supplement 5.

The sporulation efficiency of S288C diploid cells was recorded after 4 days in sporulation media at 23°C. Modest increases in sporulation efficiency were observed in cells lacking RME1, or carrying one or two extra copies of IME1, IME2, or NDT80, as indicated.
Figure 1—figure supplement 6. Deletion of UBI1 in K-to-R ubiquitin mutant strains and the in the SK1 gene deletion array.

Figure 1—figure supplement 6.

(A) UBI1 was replaced with a construct expressing the ribosomal protein Rpl40a driven by the GPD1 promoter. The final ubi1 locus does not carry a marker. Initially, UBI1 was replaced with a URA3-marked construct expressing the Cre recombinase protein from a galactose-inducible promoter, and flanked by LoxP recombination sites. After crossing this construct into the deletion collection, Cre was induced with galactose and the URA3 marker and Gal1pr-Cre construct were excised from the genome by the Cre recombinase. This excision was extremely robust and was selected for in the UBI1 backcrossed library with 5FOA (B) The steps undertaken to modify UBI1 in the entire SK1 gene deletion array are detailed.

Previous SGA screens have examined the synthetic phenotype of two (Tong et al., 2004; Schuldiner et al., 2005; Braberg et al., 2013; Costanzo et al., 2016; Tong and Boone, 2006; Collins et al., 2010) or, in a few cases, three mutations (Haber et al., 2013), whereas the ubiquitin SGA necessitates examining five loci. During conventional SGA analysis in the S288C strain, heterozygous diploids are sporulated to generate haploid cells, a subset of which contains the double mutant to be examined. The haploid selection steps require the co-segregation of an additional three haploid selectable markers to efficiently eliminate unsporulated diploid cells that would otherwise generate background (Collins et al., 2010). The desired haploid spores are relatively abundant since only five total loci are under selection; hence, the low sporulation efficiency exhibited by S288C is acceptable (Deutschbauer and Davis, 2005). In contrast, the final haploid cells in the ubiquitin SGA must contain all modified ubiquitin loci, haploid selectable markers, and a gene deletion, meaning that an exceedingly small percentage of spores will have the desired genotype. A strategy to ameliorate this problem would be to increase the efficiency of sporulation, thereby both reducing the number of unsporulated diploid cells (background), and increasing the number of correct haploid spores. Overexpression of Ime2, a positive regulator of sporulation (Neiman, 2011), was able to increase the sporulation efficiency of S288C moderately, from 12% in wild-type diploids, to 38% (Figure 1—figure supplement 5). Other genetic manipulations similarly led to only modest increases in sporulation efficiency (Figure 1—figure supplement 5). The SK1 strain background provided a more efficient and physiologic solution, as it exhibits 92% sporulation efficiency (Deutschbauer and Davis, 2005; Ben-Ari et al., 2006). The high sporulation efficiency also allowed for the omission of one haploid selection step commonly used in SGA studies, lyp1Δ selection (Figure 1—figure supplement 4, Materials and methods). Hence, all K-to-R ubiquitin mutant strains and a novel single-gene deletion library were generated in the SK1 strain background (Figure 1A, Materials and methods). To further reduce the number of selections in the ubiquitin SGA protocol and increase the percentage of spores carrying all desired mutations following sporulation, a ubi1 allele lacking the ubiquitin gene was crossed into both the ubiquitin K-to-R strains and the gene deletion array, thereby eliminating an additional selection step (Figure 1A, Figure 1—figure supplement 6A–B, Materials and methods).

The study of quantitative genetic interactions has proven to be a powerful approach to uncover novel functions of genes (Schuldiner et al., 2005; Braberg et al., 2013; Costanzo et al., 2016). Negative (synthetic) genetic interactions, which arise when a double mutant exhibits a more severe phenotype than is expected from the corresponding single mutant phenotypes, often occur when the gene pair functions in parallel or redundant pathways. Positive genetic interactions, defined as situations in which a double mutant has a phenotype equal to (epistasis) or less severe than the sickest single mutant (suppression), can occur when both genes function in the same pathway.

The ubiquitin SGA identified thousands of candidate genetic interactions between gene deletions and K-to-R ubiquitin mutations (Figure 1B). While several other large SGA screens have analyzed genetic interactions between large sets of gene deletions with known functional relationships, the ubiquitin SGA was carried out using a small number of ubiquitin mutants and an unbiased gene deletion array. Because genes with known related functions are more likely to have genetic interactions, it was expected that the ubiquitin SGA would have a lower density of true genetic interactions relative to other studies. This has the effect of decreasing the reproducibility of any single genetic interaction score. Nonetheless, two biological replicates of the ubiquitin SGA had a correlation coefficient of 0.42, in line with other large genetic interaction screens (Figure 1C).

To characterize the robustness of the ubiquitin SGA further, the correlation between genetic and known physical interactions among genes was analyzed. Genes whose protein products are known to physically interact are generally also more likely to share genetic interactions and thus tend to have highly correlated genetic interaction profiles. The enrichment of genetic interaction similarities among gene pairs whose products physically interact was compared to protein pairs that have not been reported to interact. As expected, the median correlation coefficient within physically interacting gene pairs is significantly higher than among non-interacting gene pairs (Figure 1D). Although the genetic profiles of gene deletions in the ubiquitin SGA include only 17 queries (i.e. the lysine mutants), the screen is similarly enriched for genetic similarity within physically interacting gene pairs when compared to the published chromosome biology E-MAP, wherein the genetic interaction profiles contain 754 queries and is biased for genes with known related functions (Figure 1D). Together, these analyses demonstrate the robustness and biological significance of the ubiquitin SGA.

Unbiased hierarchical clustering orders the mutant strains in the ubiquitin SGA relative to each other based on the similarity of their genetic interactions (Figure 1B). Genes that function in the same pathways or have similar functions generally have common genetic interactions. As expected, the ubiquitin SGA identified known gene modules based on their genetic interactions with the K-to-R ubiquitin mutants. For example, rim101Δ, rim21Δ, ygr122wΔ, and dfg16Δ form a cluster in the ubiquitin SGA (Figure 1B). All four genes are members of the Rim101 pathway, whose eponymous gene is a transcription factor that is activated in response to alkaline conditions in a manner dependent on Rim21, Ygr122Wp, and Dfg16 (Maeda, 2012). Other examples of known gene modules that were clustered by the ubiquitin linkage SGA include (Figure 1B): Three subunits of the chromatin-remodeling SWR-complex, SWC2, SWC3, and the catalytic subunit SWR1 (Rando and Winston, 2012); several genes in the MTC-gene cluster (MTC4, MTC6, MAY24) that was recently implicated in trafficking through the secretory pathway (Costanzo et al., 2016), as well as genes with related functions in N-linked glycosylation (OST6, ALG8) (Knauer and Lehle, 1999; Stagljar et al., 1994), endocytic protein trafficking (VFA1) (Arlt et al., 2011), or lipid biosynthesis (YOR302W) (Delbecq et al., 2000); several members of the transcription and translation-regulating Elongator complex (ELP2, 3, 6) and KTI12, a known binding partner (Krogan and Greenblatt, 2001; Petrakis et al., 2005), as well as two genes, NNF2 and PSP2, with putative related roles in transcription and splicing, respectively (Briand et al., 2001; Waldherr et al., 1993); four genes, PEX4, 8, 6, 15 that function in peroxisome biogenesis and trafficking of proteins between peroxisomes and the cytosol (Sibirny, 2016); and finally, two genes, HOM2 and HOM3, that participate in the homoserine biosynthesis pathway (Mountain et al., 1991).

The K-to-R ubiquitin mutants were also clustered based on the similarity of their genetic interactions with the gene deletion array. As expected, clustering of strains with common K-to-R mutations is generally observed (Figure 1E). For example, strains carrying the K33R mutation are clustered and have high correlation coefficients among each other. The same can be said of strains carrying the K6R and K48R mutations (Figure 1E). Interestingly, the K6R and K33R clusters are most similar to each other, suggesting similar physiological effects of mutating those ubiquitin lysines (Figure 1E). A surprising feature of the ubiquitin allele SGA is that the K11R mutation, despite the high abundance of K11 linkages in cells (Xu et al., 2009), does not drive clustering of double and triple mutants carrying K11 mutations (Figure 1E). Clustering is driven by a combination of the number and strength of common interactions between K-to-R mutants. Indeed, the K11R ubiquitin mutant has relatively few strong genetic interactions, suggesting that K11 linkages have a narrow set of functions in yeast (Figure 1F).

The ubiquitin SGA uncovered thousands of candidate genetic interactions between gene deletions and ubiquitin lysine mutations. To examine a few interactions in more detail, gene deletion strains were mated to all single lysine-to-arginine mutants, as well as wild-type ubiquitin strains. Following tetrad dissection, the growth phenotypes of single and double mutant cells were assessed. K63R mutants are included in this targeted analysis. Genes exhibiting genetic interactions with a single linkage type were examined first. The negative genetic interactions observed between ubc4Δ and K27R and between hom2Δ and K11R proved to be reproducible and specific (Figure 2A and B). Next, CDC26, a gene whose deletion exhibited genetic interactions with multiple linkages (K48R >> K11≥K33R), was analyzed. Deletion of CDC26 in combination with mutation of ubiquitin’s K11 or K48 caused significant synthetic growth defects, whereas only a mild negative interaction was observed in cdc26Δ and K33R double mutant cells (Figure 2C). Having demonstrated the robustness and reproducibility of the ubiquitin SGA, the physiological functions of ubiquitin linkage types were explored.

Figure 2. Gene deletions exhibit genetic interactions with specific ubiquitin linkage types.

Figure 2.

(A–C) Left: The genetic interaction scores of K-to-R ubiquitin mutants with deletions of UBC4 (A), HOM2 (B), or CDC26 (C); Scores less than zero represent varying degrees of negative genetic interactions (blue bars), while scores larger than zero indicate positive interactions (yellow bars). Right: Candidate genetic interactions were validated by 5-fold spot dilution assays of the indicated strains.

K11 ubiquitin linkages promote amino acid homeostasis

The K11R mutant was of special interest due to the fact that K11-linkages are the most abundant non-K48 linkages in S. cerevisiae (Xu et al., 2009), and because of their important function in metazoan cell cycle regulation (Meyer and Rape, 2014; Matsumoto et al., 2010; Wu et al., 2010). Characterization of the K11R mutant genetic interactome using gene ontology (GO) term enrichment analysis revealed a striking enrichment of genes involved in amino acid biosynthesis (Figure 3A) (Huang et al., 2009a; Huang et al., 2009b), suggesting a possible role of K11 linkages in amino acid homeostasis. To identify genes that had interactions specifically with K11R and not with other K-to-R ubiquitin mutations, the K11R mutant genetic interactome was compared to the averaged interactome of all single and double mutant strains not containing the K11R mutation (Figure 3B). Deletions of HOM2 or HOM3, two genes involved in the biosynthesis of homoserine, a threonine and methionine precursor (Mountain et al., 1991), and to a lesser extent deletion of GLY1, which encodes an enzyme that generates threonine and glycine (Liu et al., 1997), exhibited strong genetic interactions specifically with the K11R ubiquitin mutants (Figure 3B and C). These genetic interactions suggested the existence of functional redundancy between K11 linkages and threonine or methionine biosynthesis. To determine whether perturbations of threonine or methionine levels was the basis for the synthetic growth defect observed in K11R and hom2Δ or hom3Δ double mutant cells, the growth medium was supplemented with homoserine, excess threonine, or methionine. Rescue of the synthetic growth defect by either homoserine or threonine suggested that K11-linked polyubiquitin chains function redundantly with threonine biosynthesis (Figure 3D).

Figure 3. K11 linkages are functionally redundant with threonine biosynthesis and promote threonine import.

(A) Gene Ontology (GO) term enrichment analysis was performed on the genetic interactions of the K11R ubiquitin mutant having genetic interaction scores of −2 or less. The fold enrichment of biological function GO terms (BP_Direct) that were significantly enriched is shown. (B) The genetic interaction scores of the K11R ubiquitin mutant were plotted against the averaged genetic interaction scores of all K-to-R strains not containing the K11R mutation. Highlighted genes had negative interactions specifically with the K11R ubiquitin mutant, and had related functions in amino acid biosynthesis. (C) HOM2 and HOM3 are required for the biosynthesis of homoserine, a methionine and threonine precursor. (D) The negative genetic interactions of the K11R ubiquitin mutant with deletions of HOM2 or HOM3 were validated by fivefold spot dilution assays of the indicated strains. Excess homoserine, threonine, or methionine was added to C-leu plates as noted. (E) The correlation coefficient between the genetic interactions of the K11R ubiquitin mutant and single gene deletion strains was calculated. The genetic interactome of the K11R ubiquitin mutant is most similar to the genetic interactions of strains carrying deletions of GNP1 or YDR509W. (F) The import of tritiated threonine into wild-type and K11R ubiquitin mutant cells was measured by scintillation counting. The Y-axis shows the measured counts per minute (CPM) divided by optical density (OD600) of the cell cultures (CPM/OD600). (G) A negative genetic interaction between deletions of HOM2 and DOA10 is shown by spot dilution assays of the indicated strains. The genetic interaction is abrogated by addition of homoserine to C-leu plates.

Figure 3.

Figure 3—figure supplement 1. Gnp1 is a major threonine permease.

Figure 3—figure supplement 1.

The import of tritiated threonine into wild-type cells and cells lacking Gnp1 was measured by scintillation counting. The Y-axis shows the measured counts per minute (CPM) divided by optical density (OD600) of the cell cultures (CPM/OD600).

Whereas negative genetic interactions point to redundancy between genes and ubiquitin linkage types, the deletions of genes that function in the same pathway as a specific ubiquitin linkage are likely to have genetic interactions that are similar to that linkage type. Comparison of a comprehensive yeast genetic interaction network to the genetic interactome of the K11R ubiquitin mutant revealed that it is most similar to deletions of GNP1 (Ryan et al., 2012), a high-affinity threonine permease (Figure 3—figure supplement 1) (Regenberg et al., 1999), and YDR509W, a dubious open-reading frame that overlaps the N-terminus of GNP1 and is thus likely to also abrogate GNP1 expression (Fisk et al., 2006) (Figure 3E). The similarity between the K11R mutant and gnp1Δ genetic interactomes suggested that K11 linkages play a role in promoting threonine import. To assess that model, the import of radioactively labeled threonine into wild-type and K11R ubiquitin cells was measured, revealing a significant defect in the K11R ubiquitin mutant, and thus showing that K11 linkages promote threonine import (Figure 3F). This previously unreported function of K11-linked polyubiquitin chains in amino acid import is likely the underlying basis of the synthetic growth defect observed in K11R hom2Δ or K11R hom3Δ cells.

Polyubiquitin chains are synthesized by E3 ubiquitin ligases (Hershko and Ciechanover, 1998). If a particular E3 ligase were involved in the K11-mediated import of threonine, it would be expected to also have negative genetic interactions with hom2Δ or hom3Δ. Deletion of DOA10, an endoplasmic-reticulum-resident E3 ubiquitin ligase that is responsible for approximately 50% of K11 linkages in yeast cells (Zattas and Hochstrasser, 2015; Xu et al., 2009), in combination with hom2Δ also led to a synthetic growth defect that was rescued by homoserine (Figure 3G), suggesting that Doa10, along with K11 ubiquitin chains, contribute to threonine import. These results suggest that the Doa10-mediated ubiquitination of a substrate, or a set of substrates, might regulate amino acid import. The Doa10-dependent ubiquitinome was analyzed using quantitative mass spectrometry and ubiquitin-remnant enrichment. While known Doa10 substrates were less ubiquitinated in cells lacking Doa10, or its cognate E2s Ubc6 and Ubc7, the substrate responsible for the role of Doa10 in amino acid homeostasis remains unknown (Supplementary file 5). Nonetheless, the discovery that Doa10 is an E3 ligase that contributes to the function of K11-linkages in amino acid import counters models suggesting the observed amino acid import defect is due to non-specific perturbations of ubiquitin.

K11 ubiquitin linkages contribute to mitotic progression

The anaphase promoting complex (APC) is a highly conserved and essential E3 ubiquitin ligase that governs the metaphase to anaphase transition and mitotic exit by ubiquitinating several substrates, including securin and S and M-phase cyclins (Sumara et al., 2008; Tyers and Jorgensen, 2000; Thornton et al., 2003). In yeast, the APC cooperates with two E2 ubiquitin conjugases, Ubc4 and Ubc1, to decorate its substrates with polyubiquitin chains and target them for proteasomal degradation (Rodrigo-Brenni and Morgan, 2007). Ubc4 is a promiscuous E2 that monoubiquitinates or initiates short ubiquitin chains on substrates (Arnason and Ellison, 1994; Kirkpatrick et al., 2006). Ubc1 subsequently extends those initial modifications with long and homogenous K48-linked ubiquitin chains (Rodrigo-Brenni and Morgan, 2007; Rodrigo-Brenni et al., 2010). K48 of ubiquitin is necessary for processive APC-substrate ubiquitination in vitro (Rodrigo-Brenni and Morgan, 2007), and is the only linkage type required for normal cell cycle progression in vivo (Rodrigo-Brenni et al., 2010). At high temperatures, a non-essential subunit of the APC, Cdc26, aids in the assembly and promotes the stability, of the APC holoenzyme (Schwickart et al., 2004; Zachariae et al., 1998a). As expected given the well-established role of K48 linkages in APC-mediated proteasomal degradation, K48R ubiquitin mutant cells lacking Cdc26 exhibit a significant growth defect (Figure 2C). Interestingly, deletion of CDC26 in K11R mutant cells also leads to a strong synthetic growth defect (Figure 2C), suggesting a possible contribution of K11 linkages to APC function.

Although K11-linked polyubiquitin chains had not been previously reported to function in APC-substrate degradation in yeast, their role in metazoan APC-substrate turnover is well understood (Meyer and Rape, 2014; Williamson et al., 2009; Matsumoto et al., 2010; Wu et al., 2010; Jin et al., 2008; Yau et al., 2017). Analogous to the yeast APC, the metazoan APC interacts with two E2 enzymes, Ube2C and Ube2S, that sequentially ubiquitinate substrates (Wu et al., 2010; Brown et al., 2016). Ube2c initially modifies substrates with monoubiquitin or short chains that are then elongated by Ube2S with K11-linked chains (Wu et al., 2010). The negative genetic interaction between K11R and cdc26Δ suggested that K11 linkages might also be important for the regulation of APC substrates in yeast. Indeed, cell cycle analysis experiments with cells lacking Cdc26 revealed that the cell-cycle-regulated levels of securin and several cyclins were altered in K11R ubiquitin mutants relative to cells expressing wild-type ubiquitin (Figure 4A). For example, the mitotic cyclin Clb2 persisted much longer during mitosis in K11R cells, with its disappearance being delayed by almost 30 min (Figure 4A). The levels of the S/M cyclin, Clb3, and of the Separase-inhibitor, Securin (Pds1), were also misregulated in K11R mutant cells, although to a lesser extent than Clb2 (Figure 4A). Clb5, an S-phase cyclin, is normally targeted for degradation during the M and G1 phases by the APC (Ostapenko et al., 2015; Shirayama et al., 1999). Its expression during both M and G1 was elevated in K11R mutant cells, suggesting that K11 was required for complete turnover of this substrate (Figure 4A).

Figure 4. K11 linkages contribute to APC-substrate turnover.

(A) Wild type and K11R ubiquitin mutant cells lacking Cdc26 were synchronized in G1 phase with α factor, then released into the cell cycle. Samples were taken at the specified times after release and analyzed by probing western blots for the indicated proteins. (B, C) cdc26Δ cells expressing wild type or K11R ubiquitin were arrested in G1 with α-factor. Cells were washed in fresh media to release from the arrest and, after sixty minutes, protein synthesis was blocked by the addition of cycloheximide. The APC was active at this time point, as measured by Pds1 and Clb5 turnover (Panel 4A). Samples were taken at the specified times after cycloheximide addition and analyzed by probing western blots for the indicated proteins. Bands were quantified using the Licor Image Studio Software and were normalized to Cdc28 or PSTAIR as loading controls (n = 3). A second order polynomial best-fit line was calculated. Half lives were calculated by determining the slope of the line tangent to the best fit curve at T = 0. (D) Cells were synchronized in G1 phase with α factor. During the G1 arrest, Clb2-6xHis-3xFlag expression was induced by the addition of galactose, and cells were shifted to 37°C. Clb2 synthesis was then blocked by removal of galactose, and addition of glucose and cycloheximide. The levels of Clb2-6xHis-3xFlag in wild-type and K11R ubiquitin cells lacking Cdc26 were analyzed by western blotting at the indicated times. Cdc28 was examined as a loading control using Anti-PSTAIR antibody. Bands were quantified as in Figure 4C. (E) A radioactively labeled fragment of Hsl1, amino acids 667–872, was incubated with or without APC/Cdh1, Ubc4, and different forms of ubiquitin, as indicated. The ubiquitination of Hsl1 was analyzed by SDS-PAGE and autoradiography. (F) All lysine residues on Hsl1 (667-872) were mutated to arginine, except for two lysines (K775, 812) that are part of 2 KEN box degrons, and lysine 747, which has been previously reported as being ubiquitinated. This Hsl1 fragment is termed Hsl1-3K, and was analyzed as in 4E. (G) A model describing the well-established role of K11 linkages in mammalian cells, and their function in yeast APC substrate degradation as suggested by the data presented here.

Figure 4.

Figure 4—figure supplement 1. Cell cycle profiling by FACS.

Figure 4—figure supplement 1.

(A) WT and K11R mutant cells were treated as in Figure 4B and analyzed by flow cytometry. (B) WT and K11R mutant cells were treated as in Figure 4D and analyzed by flow cytometry. Importantly, the high flocculence of the SK1 strain renders interpretation of cell cycle profiles by FACS difficult (Cox and Mann, 2008).

To ascertain whether the misregulation of APC substrates was caused by a defect in their turnover, and not due to other effects of mutating K11, cdc26Δ cells were synchronized in G1 phase, and the half life of APC substrates was examined 60 min after release from G1, when the APC was active as evidenced by securin turnover (Figure 4A; Figure 4—figure supplement 1A). The turnover of all examined substrates is delayed in K11R mutant cells (Figure 4B,C). Interestingly, the turnover of substrates stalls after approximately 10 min in cycloheximide, likely due to degradation of APC substrate adaptors (Foe et al., 2011). The half-lives of substrates were estimated by fitting a second-order polynomial trendline to the data and subsequently calculating the slope of the tangent line at t = 0 min. On average, the half-lives of examined substrates were extended by approximately 2.5 fold in the K11R ubiquitin mutant (Figure 4C). Because defects in cell cycle progression in K11R mutant cells could explain the delay in APC substrate turnover, it was necessary to determine the half-lives of APC substrates independently of cell cycle progression. Ectopic expression of Clb2 in G1-arrested cells, which have active APC (Zachariae et al., 1998b), permitted the analysis of the Clb2 half-life in cells that were in the same cell cycle stage. The half-life of Clb2 was analyzed after addition of cycloheximide in G1 phase, revealing a delay in Clb2 turnover in K11R mutant cells (Figure 4D, Figure 4—figure supplement 1B).

To examine K11 chain usage by the APC biochemically, the capacity of the yeast APC to modify substrates with K11-linked polyubiquitin chains was analyzed in vitro. The ubiquitination of an in vitro-translated fragment of the APC substrate Hsl1, by APC-Cdh1 and Ubc4, the initiating APC-cognate E2, was assayed in the presence of either WT, K0 (K6,11,27,29,33,48,63R), or K11-only (K6,27,29,33,48,63R) ubiquitin. Under these conditions, Hsl1 is strongly ubiquitinated in the presence of WT ubiquitin and, to a slightly lesser extent, in reactions containing K11-only ubiquitin (Figure 4E). In contrast, Hsl1 ubiquitination is significantly reduced in reactions containing K0 ubiquitin, as compared to K11-only. The ubiquitin smear observed when Hsl1 is incubated with K0 ubiquitin likely represents the attachment of monoubiquitins to several of the 21 lysines in the Hsl1 fragment used in the experiments. Significantly, the slower electrophoretic mobility of Hsl1 modified with K11-only ubiquitin relative to K0 ubiquitin shows that the yeast APC extends monoubiquitin modifications of Hsl1 with K11-linked ubiquitin chains in vitro.

To ascertain the length of homogenous K11-linked chains generated by the yeast APC, all lysines of Hsl1 were mutated to arginine, except for two lysines that constitute two KEN-box degrons and K747 of Hsl1, which has been previously reported to be ubiquitinated. This mutant form of Hsl1, termed Hsl1-3K, allowed for the detection of Hsl1 ubiquitination at a single lysine residue (K747). The observation that Hsl1-3K is decorated with a single monoubiquitin in reactions containing K0 ubiquitin confirmed that a one lysine, likely K747, is ubiquitinated by the APC in Hsl1-3K (Figure 4F). The reduced level of ubiquitination observed for Hsl1-3K relative to WT Hsl1 (compare the loss of unmodified substrate in lane 5 of Figure 4E and F) suggests that recognition of this mutant substrate by the APC is strongly compromised, which is likely to compromise the enzyme’s processivity significantly. Nonetheless, the substrate is polyubiquitinated in the presence WT ubiquitin (Figure 4F). Significantly, the monoubiquitination of Hsl1-3K in the presence of K11-only ubiquitin is extended with at least two further ubiquitins, leading to a chain composed of at least three ubiquitin protomers that are necessarily linked through lysine-11 of ubiquitin (Figure 4F). The higher level of Hsl1-3K ubiquitination seen with WT relative to K11-only ubiquitin (Figure 4F, lanes 3 and 4) could either represent ubiquitin chain branches or the combinatorial effect of a highly mutated ubiquitin and substrate. Altogether, our results show that K11 linkages contribute to APC-substrate turnover in yeast.

Discussion

Although some large-scale proteomics studies have advanced our understanding of the physiological roles of specific polyubiquitin chain types, much of the progress has occurred through the study of single pathways. A significant challenge for the ubiquitin field has been the partial redundancy between ubiquitin linkage types (Xu et al., 2009). The analysis of genetic interactions, however, reveals phenotypic functional relationships between genes, thereby facilitating the discovery of physiologically important functions of genes. The synthetic genetic array (SGA) reported here represents the first comprehensive genetic analysis of lysine-to-arginine ubiquitin mutant alleles. This SGA leverages the power of yeast genetics to uncover physiologically important functional relationships between ubiquitin linkage types and thousands of genes.

The ubiquitin linkage SGA necessitated the development of a novel SGA protocol and reagents to permit the analysis of genetic interactions in cells carrying five mutations, as well as haploid selectable markers. The large number of loci under selection meant that an extremely small number of spores carried the desired genotype for SGA analysis. To increase the number of spores, the ubiquitin linkage SGA was carried out in the SK1 strain background, which exhibits about eightfold higher sporulation efficiency relative to S288C (Deutschbauer and Davis, 2005), the yeast strain most commonly used in SGA studies. This also permitted the omission of a haploid selection step by decreasing background unsporulated diploids. The ubiquitin linkage SGA therefore required the development of a new gene deletion library in the SK1 background. To increase the percentage of spores carrying the desired genotype for SGA analysis, the UBI1 locus was replaced in the entire SK1 deletion library, as well as in the panel of K-to-R ubiquitin mutant strains, thereby reducing the loci under selection. Ultimately, the technical advancements described here reduced, from eight to six, the number of loci under selection, thereby making the ubiquitin linkage SGA feasible.

A novel role of K11 linkages in promoting amino acid import adds to already well-established roles of the ubiquitin-proteasome system in that process. First, expression of amino acid permeases is promoted by the transcription factors Stp1/2, which are proteolytically processed into their active forms in a ubiquitin-dependent process utilizing K48 ubiquitin linkages (Ljungdahl, 2009; Petroski and Deshaies, 2005). We found that neither this pathway nor the levels or localization of the threonine permease Gnp1 are affected by the K11R ubiquitin mutation (data not shown). Conversely, downregulation of permeases occurs when an essential E3 ligase, Rsp5, modifies their intracellular domains with monoubiquitin and short K63-linked polyubiquitin chains, thereby triggering endocytosis and vacuolar targeting (MacGurn et al., 2012; Lauwers et al., 2010; Kim and Huibregtse, 2009). The observed enrichment of threonine biosynthesis genes in the genetic interactions of the K11R ubiquitin mutant would suggest a specific function in threonine import. A more likely model, however, is that threonine homeostasis is more susceptible to perturbations, perhaps due to relatively low redundancy in its modes of import (Regenberg et al., 1999). Thus, our data may point to a role for K11 linkages with many importers whose functional impairment is not phenotypic.

The ubiquitin allele SGA also revealed a previously unreported contribution of K11 linkages to cell cycle regulation. The genetic interaction between K48 linkages and CDC26 was not unexpected, as it is understood that the yeast APC decorates its substrates with K48-linked ubiquitin chains (Rodrigo-Brenni et al., 2010). The genetic interaction between K11 linkages and CDC26 identified by the ubiquitin allele SGA led to the recognition that K11 linkages also contribute to APC-substrate turnover in vivo, and that the APC can directly modify a substrate with K11-linked polyubiquitin in vitro. These results suggest that the metazoan APC, which modifies its substrates with K11-linked ubiquitin chains (Meyer and Rape, 2014; Williamson et al., 2009; Matsumoto et al., 2010; Wu et al., 2010; Jin et al., 2008; Yau et al., 2017), and the yeast APC are more alike than previously appreciated.

The metazoan and yeast APC both interact with two E2 enzymes that sequentially modify substrates (Meyer and Rape, 2014; Wu et al., 2010; Rodrigo-Brenni and Morgan, 2007; Garnett et al., 2009). The initiating E2 enzymes, Ube2C in metazoans and Ubc4 in yeast, modify substrates with single ubiquitins and short chains (Kirkpatrick et al., 2006). Because initiating E2s must be able to modify lysines on substrates, which can exist in diverse structural and chemical environments, they necessarily lack strong lysine preference (Arnason and Ellison, 1994; Kirkpatrick et al., 2006). Ubc4 or Ube2c-mediated modifications are then elongated by Ube2S in metazoans or Ubc1 in yeast. In contrast to initiating E2s, Ube2S and Ubc1 exhibit a strong preference for ubiquitin’s lysine 11 and 48, respectively (Rodrigo-Brenni et al., 2010; Wickliffe et al., 2011), and are unable to efficiently modify lysines on substrates (Wu et al., 2010; Rodrigo-Brenni and Morgan, 2007). In light of preceding APC studies, the genetic, molecular, and biochemical results presented here suggest that the yeast APC modifies its substrates with a short, Ubc4-mediated heterogeneous base, in which K11-linked chains are most functionally important (Kirkpatrick et al., 2006). Ubc1 then extends those initial modifications with long K48-linked polyubiquitin chains (Rodrigo-Brenni and Morgan, 2007; Rodrigo-Brenni et al., 2010). This model (Figure 4G) differs from the well-established mechanism of the metazoan APC, which modifies substrates with a base of short chains with K48 and other linkages, which then branch into long K11-linked chains. The fact that the contribution of K11 linkages to APC-substrate turnover is appreciable only in cells without Cdc26 suggests a nuanced role of K11 linkages in yeast, similar to metazoans, wherein disruption of the gene encoding the K11-specific E2, Ube2s, is not lethal. Pivotal work has shown that K11/K48 branched chains significantly enhance substrate degradation in mammalian cells (Meyer and Rape, 2014; Yau et al., 2017). Whether this holds true in yeast has not been studied, but would provide an appealing explanation for the use of K11-linkages in APC function. An appealing model is that this allows turnover of substrates that must be eliminated immediately and synchronously, like securin, to have priority over less urgent quality control activities.

Detailed analysis of genetic interactions uncovered by the ubiquitin linkage SGA analysis has enabled us to discover two novel physiological functions of K11 ubiquitin linkages in two important processes: amino acid transport and cell cycle regulation. Altogether, the ubiquitin allele SGA has broadened our global understanding of the functions of polyubiquitin chain types by revealing their genetic interactomes, and demonstrated the utility of genetic analysis for interrogating the complexity of the ubiquitin-proteasome system.

Materials and methods

Generation of an SK1 gene deletion library

SK1 diploids of genotype his3/his3 ura3/ura3 CAN1/can1::STE2pr-SpHIS5 were transformed with a PCR-generated cassette containing the KanMX4 module flanked by ORF-specific homology. Transformants were selected by their dominant resistance to geneticin (G148). Correct replacement of the target locus with the KanMX4 module was verified by the appearance of PCR products of expected size. The resulting heterozygotes were sporulated at 25°C for 2 days. To select for haploids of MATa, and carrying the STE2pr-SpHIS5 at the can1 locus, cells were pinned onto SD +canavanine + uracil – histidine plates and incubated at 30°C for 2 days. To select for cells carrying single-gene deletions, haploids were then transferred to plates containing 400 mg/L G418 plates and incubated at 30°C for 24 hr.

Deletion of UBI1

The ubiquitin linkage SGA required the analysis of genetic interactions in cells carrying mutations in all four ubiquitin loci, a single-gene deletion, as well as haploid selectable markers. To decrease the number of loci under selection, and thereby increase the percentage of spores with the desired genotype, the UBI1 locus was deleted in all strains in the SK1 Deletion library, as well as in the panel of K-to-R ubiquitin mutant strains. UBI1 was replaced with a construct expressing the ribosomal protein Rpl40A from the constitutive GPD promoter (Figure 1—figure supplement 6). This decreased the number of selection steps required for the ubiquitin linkage SGA to 6: three ubiquitin loci, one gene deletion, two haploid and mating type selection markers.

As outlined in Figure 1—figure supplement 6, a 500 µL liquid culture of strain DS1 of the genotype Mat alpha; his3; ura3; CAN1; ubi1Δ::LoxP-GAL1pr-Cre-URA3-LoxP-GPDpr-RPL40A was spread on a C-uracil plate to generate a lawn of cells that was subsequently pinned into the 384 format to allow mating to the SK1 gene deletion library. It is worth noting that the GAL1pr-Cre construct could not be maintained in bacteria due to leakiness of the promoter, and was therefore amplified from yeast genomic DNA directly. After mating to the SK1 gene deletion array on YPAD medium, diploids were selected using C-uracil +G418 plates. After sporulation for 2 days, haploids were selected first on C-uracil for 24 hr; then on C-uracil +G418 for 2 days. Haploids were then plated on 2% galactose containing plates for 2 days to induce Cre recombinase that deleted the endogenous ubiquitin in UBI1, as well as URA3 and the Cre recombinase due to the position of the LoxP sites. The modified library was plated on 5-fluoro-orotic acid (FOA) plates and incubated at 30°C for 24 hr. This serves as a negative selection for the URA3 auxotrophic marker, such that cells containing a functional URA3 gene will die on FOA plates (Boeke et al., 1984). FOA negative selection was performed consecutively three times to ensure URA3 deletion. The modified ubi1 locus was amplified from the library using primers outside the homology arms and sequenced to confirm the successful recombination event. Deletion of UBI1 did not result in changes in the total ubiquitin levels or doubling time, in agreement with a previous report (Hanna et al., 2003).

Generation of K-to-R ubiquitin mutant strains

To express K-to-R mutant ubiquitin alleles from a strong, constitutive promoter, TEF1, HYP2, PYK1, PDC1, and GPD promoters were analyzed, and the GPD promoter was chosen since it resulted in the highest ubiquitin expression in agreement with a previous report (Partow et al., 2010).

Plasmids generated, and the relevant cloning information, are listed in Supplementary file 1. Generation of the ubi1 allele is discussed above.

The UBI2 locus was replaced with two tandem copies of the GPD promoter driving expression of the ribosomal protein Rpl40A (Figure 1—figure supplement 1). The modified locus was marked with the Hygromycin resistance gene. Deletion of UBI2 resulted in a doubling time of 2 hr, compared to 1.6 hr for wild-type cells, in agreement with a previous report (Jackson and Durocher, 2013). The modified ubi2 locus with two tandem GPDpr-RPL40A copies exhibited a normal doubling time.

The endogenous UBI3 locus encodes a hybrid of ubiquitin fused to the ribosomal protein gene RPS31. The locus was replaced with a construct expressing a polypeptide composed of three tandem ubiquitin copies fused to one RPS31 copy, under the control of the GPD promoter. An additional RPS31 gene was placed under the control of the GPD promoter at this locus (Figure 1—figure supplement 1). Several UBI3 modifications were attempted prior to selecting this construct. Deletion of UBI3 resulted in a doubling time of 7 hr, in agreement with a previous report (Jackson and Durocher, 2013). Multiple ubi3 alleles were generated with varying numbers of GPDpr-RPS31 copies. Although there was a correlation between the number of RPS31 copies and doubling time, even five copies of GPDpr-RPS31 resulted in a slow doubling time of 3 hr. It is suggested the ubiquitin fusion protein assists in ribosomal protein expression (Finley et al., 1989). Therefore, given the possibility that ubiquitin acts as a chaperone for Rps31, three tandem copies of ubiquitin were fused to RPS31. An additional GPDpr-RPS31 copy was integrated, and the ubi3 locus was marked with URA3 (Figure 1—figure supplement 1). The resulting ubi3 allele led to growth rates similar to wild type.

The UBI4 locus normally encodes five tandem copies of ubiquitin, expressed as single polypeptide. UBI4 was replaced with a two copies of a construct expressing, under the control of the GPD promoter, ubiquitin including the C-terminal asparagine found in endogenous UBI4 and which is proteolytically processed to release mature ubiquitin (Finley et al., 2012; Ozkaynak et al., 1987). This locus was marked with a Nourseothricin (NAT) resistance cassette (Figure 1—figure supplement 1).

A strain expressing low levels of wild-type ubiquitin was included to control for the potential effects of altered ubiquitin levels. The strain differs from other strains in this study at ubi4, which is replaced only with the NAT resistance cassette. Thus, ubiquitin is only expressed from ubi3 (Figure 1—figure supplement 3A).

Lysine 48 of ubiquitin is essential, therefore, the K48R ubiquitin mutant strain was modified to express one copy of wild-type ubiquitin from the GPD promoter-driven triple-ubiquitin fusion at ubi3 (Figure 1—figure supplement 3B). Double mutants carrying the K48R mutation and another lysine mutation expressed one copy of double lysine mutant ubiquitin (K11R K48R, for example) and two copies of single mutant ubiquitin (K11R, for example) at ubi3. Double mutant ubiquitin was expressed from ubi4.

To integrate the constructs described above, a diploid strain homozygous for the engineered ubi1 locus was transformed with the ubi2-targeting construct. Transformants were selected on hygromycin plates, and then transformed with the ubi3-targeting constructs carrying the various ubiquitin mutations. The resulting transformants were selected on plates lacking uracil, then sporulated. Triple mutant ubi1; ubi2; ubi3 cells of mating type alpha were selected by growth on plates lacking uracil, and containing hygromycin. The ubi4 targeting constructs carrying ubiquitin mutations were introduced into a wild-type diploid strain. The strain was sporulated, and ubi4 mutant haploids of mating type a were selected by their growth on nourseothricin-containing plates. ubi1; ubi2; ubi3 cells were mated to cells carrying the ubi4 mutant locus. Diploids were sporulated, and haploids carrying all modified ubiquitin loci were selected.

Optimization and establishment of the ubiquitin linkage SGA protocol

A detailed four-marker SK1 SGA protocol is outlined in Figure 1—figure supplement 4, and is modified from the two-marker S288C SGA protocol with the key optimization steps described below (Schuldiner et al., 2006). To ensure the quality of the genetic interaction screen, multiple optimizations were performed at various steps of the ubiquitin linkage SGA. During the pinning steps with a Singer ROTOR instrument, a mixed pinning setup was used to maximize the number of cells transferred. Linkage analysis was used in pilot screens to determine whether the selections were functional and recovered accurate genetic interactions. Specifically, since the SGA is selecting for haploid cells with modified ubiquitin loci, crossing all K-to-R ubiquitin strains to the ubi2 deletion strain from the SK1 deletion library will result in lethality.

Sporulation of the SK1 strain is 90–100% efficient compared to the 10–16% sporulation efficiency of S288C strain (Deutschbauer and Davis, 2005). Conventional SGA studies using S288C sporulate cells for 5 days. The high sporulation efficiency of SK1 allowed sporulation for 2 days at 25°C, thereby shortening the duration of the genetic screen significantly.

It is essential to determine the optimal concentration of G418, as this selection is required to select against the wild-type allele of the K-to-R mutant strains and select for the specific gene deletion that comes from the library. Previous SGA studies have used between 100 mg/L and 200 mg/L G418 (Collins et al., 2010). Titration of various G418 concentrations for SK1 indicated that this strain requires higher G418 concentrations. 350 mg/L was used for the ubiquitin linkage SGA.

After sporulation, canavanine is used to kill the remaining diploids. In the S288C-SGA, since sporulation is inefficient, 50 mg/L Canavanine is included throughout the SGA workflow (following sporulation) (Figure 1—figure supplement 4) (Geng et al., 2012). In the SK1 SGA, including 50 mg/L Canavanine along with the mutant selection steps (e.g. 50 mg/L Canavanine +350 mg/L G418) resulted in sickness and changes in the colony sizes (data not shown). Titration of canavanine, in combination with the various selection drugs used in the SGA workflow, revealed that 10 mg/L of canavanine was sufficient to kill diploids without causing growth defects. 50 mg/L of canavanine was still used for haploid selection following sporulation, and 10 mg/L was included in all subsequent selection plates (Figure 1—figure supplement 4).

The K-to-R ubiquitin loci were selected prior to selecting for the deletion array, as linkage analysis with ubi2 revealed that the reverse order did not efficiently select for cells carrying the modified ubiquitin loci. Haploid mutant selections were performed in the following order: (1) C-uracil plates (ubi3), 200 mg/L hygromycin (ubi2); (2) 100 mg/L Nourseothricin (ubi4); (3) 350 mg/L G418 (single gene deletions). In each drug selection step, the previous selection drug or condition was included to ensure precise mutant selections (Figure 1—figure supplement 4).

SGA data analysis

The final double mutant selection plates were grown at 30°C for 48 hr, and then photographed. Colony sizes were recorded and normalized, and genetic interaction scores (S-scores) were calculated using established SGA protocols (Collins et al., 2010; Collins et al., 2006). Of the 2655 gene deletion strains used in the final analysis, 576 strains were analyzed based on three technical replicates, while the rest were analyzed based on two biological replicates, each with three technical replicates. The two biological replicates were used to compute the correlation coefficient between replicates of the screen. Hierarchical clustering of mutants was performed using the Gene Cluster 3.0 software, and data was visualized with Java TreeView (https://sourceforge.net/projects/jtreeview). The Pearson correlation coefficient between the genetic interactions of the K-to-R ubiquitin mutants and the genetic interactions of thousands of single-gene deletions was calculated using a combined budding yeast genetic interactome data set (Ryan et al., 2012). Correlation coefficients calculated from genetic interaction profiles with 500 or more genetic interaction pairs are graphed in Figure 3E. For analysis of gene ontology term enrichment, the genetic interactions of K-to-R ubiquitin mutants with S-scores of −2 or less were analyzed for the enrichment of biological process (BP_Direct) GO terms using the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool (Huang et al., 2009a; Huang et al., 2009b).

Analysis of genetic similarity enrichment within physically interacting gene pairs

The degree of enrichment of genetic interaction profile similarity among gene pairs that physically interact was compared to gene pairs that are not known to physically interact. This comparison was carried out using the genetic interactions in the ubiquitin SGA, as well as the chromosome biology E-MAP (Collins et al., 2007). The analysis was done for the 392 gene deletions that were present in both screens. Physical interaction data was obtained from Collins et al. (2007). A threshold of a PE score greater than two was used to determine gene pairs that physically interact. The Pearson correlation coefficient for all gene deletions was calculated based on the similarity of their genetic interaction profiles in each screen. The correlation coefficients of physically interacting and non-interacting genes were graphed.

Strains, cell culture conditions, and plasmids

Plasmids and strains used in this study are listed in Supplementary file 1 and 2, respectively. All yeast strains in this study are in the SK1 background. Cells were cultured at 30°C on YM-1 media supplemented with 2% dextrose, unless otherwise noted. Selective media lacking specific amino acids or nucleobases was made using Complete Supplement Mixture (CSM) from Sunrise Sciences, supplemented with yeast nitrogen base and 2% glucose. Cloning of constructs and transformations were done using standard techniques.

Validation of genetic interactions

K-to-R ubiquitin mutant strains (DS368-397, Supplementary file 2) were mated to desired single-gene deletions from the SK1 deletion library. Diploid cells were sporulated at 23°C, and tetrads were dissected on YM-1 plates with 2% dextrose. Spores were then genotyped by replica-plating onto appropriate plates, and the desired mutant spores were selected. Petite colonies were identified by lack of growth on plates containing 3% glycerol as the carbon source and discarded. To analyze the growth of strains, overnight cultures were normalized to an OD600 value of 1, then five-fold serial dilutions were spotted onto CSM plates supplemented with 2% glucose, unless otherwise indicated, grown for 3 days at 30°C and then scanned. It is worth noting that, as with all SGA analyses, a quantitative validation of genetic interactions requires the replication of the full SGA protocol since the presence of any or all of the four selectable markers used could affect the genetic interaction.

Threonine uptake assay

Overnight cultures were diluted to OD600 of 0.05 in B-liquid, pH4.5, supplemented with 0.01 mg/mL histidine, 0.02 mg/mL uracil, and 0.1 mM threonine. When cultures reached OD600 of 0.3, 6 mL were collected for time point zero and placed on ice with 120 μL of 1M NaN3. The cells were incubated on ice for the duration of the experiment, then 0.5uCi of 3–3 H L-threonine (American Radiolabeled Chemicals, ART 0330) were added to time point zero, and mixed by inverting once. Cells were then immediately collected by filtration with glass microfiber filters (Whatman, 934-AH), and then washed with 25 mL of cold water. The filter was then placed in a scintillation vial and dried overnight at 55°C. To begin the time-course experiment, 3uCi of 3–3 H L-threonine were added to each 34 mL culture. For each indicated time point, 6 mL were collected by filtration as described above. The OD600 of the cultures was recorded at each time point. Radioactivity was measured by liquid scintillation counting (Research Products International, Bio-Safe NA; Beckman, LS6500) for 5 min. Experiments were performed in triplicate. The slope was calculated by linear regression, and a two-sample T-test was performed to determine statistical significance.

Quantitative proteomics

The indicated strains were grown to mid-log phase in C-Lys media containing either 13C6, 15N2 (Cambridge Isotope Laboratories, Tewksbury MA), or unlabeled lysine, both at 0.06 mg/mL. Sufficient incorporation of labeled lysine was attained by allowing cells grow for more than eight generations. Cells were collected by centrifugation, washed with cold HPLC-grade water and flash frozen. Cell pellets were then resuspended in lysis buffer (8M urea, 0.1M Tris-HCl pH 8, 150 mM NaCl, Roche mini protease inhibitor tablet without EDTA) and lysed by bead beating (20 1-min bursts with rests of 2 min following each cycle). Lysates were collected and incubated at room temperature with rotation. The lysates were then clarified by centrifugation at 17,000 x g for 10 min, followed by a second clarification cycle on the collected supernatant. The protein concentration in each sample was determined by BCA (Pierce) and samples were normalized accordingly. Disulfides were reduced with 4 mM TCEP and cysteines alkylated with 10 mM iodoacetamide, both for 30 min at room temperature in the dark. Excess iodoacetamide was quenched with 10 mM DTT for 30 min at room temperature in the dark. The samples were diluted to reduce the urea concentration to 2M with 0.1M Tris-HCl pH 8. Trypsin (in 50 mM acetic acid) was added at a ratio of 1 mg of enzyme to 100 mg of protein in the sample, and samples were incubated at room temperature overnight with end-to-end rotation.

After digestion, 10% TFA was added to a final concentration of 0.3–0.1% TFA, with pH of final solution <3. Insoluble material was precipitated by centrifugation and peptides were loaded onto a Sep Pak tC18 column that had been activated with 1 mL 80% ACN/0.1% TFA and equilibrated with 3 × 1 mL 0.1% TFA. Columns were washed with 5 × 1 mL 0.1 TFA and eluted with 1 mL 40% ACN/0.1% TFA prior to lyophilization. Diglycine-modified peptides were immunoprecipitated using an antibody specific for the K-GG motif characteristic of trypsinized, Ub-modified peptides (UbiScan, Cell Signaling Technology). Immunoprecipitates were then desalted using C18 Ultra MicroSpin columns (Nest Group), evaporated to dryness, and reconstituted in 0.1% formic acid for LC-MS/MS analysis.

Samples were analyzed on a Thermo Fisher Orbitrap Fusion mass spectrometry system equipped with a Easy nLC 1200 ultra-high pressure liquid chromatography system interfaced via a Nanospray Flex nanoelectrospray source. Samples were injected on a C18 reverse phase column (25 cm x 75 μm packed with ReprosilPur C18 AQ 1.9 μm particles). Peptides were separated by an organic gradient from 5% to 30% ACN in 0.1% formic acid over 120 min at a flow rate of 300 nL/min. The MS continuously acquired spectra in a data-dependent manner throughout the gradient, acquiring a full scan in the Orbitrap (at 120,000 resolution with an AGC target of 200,000 and a maximum injection time of 100 ms) followed by as many MS/MS scans as could be acquired on the most abundant ions in 3 s in the dual linear ion trap (rapid scan type with an intensity threshold of 5000, HCD collision energy of 29%, AGC target of 10,000, a maximum injection time of 35 ms, and an isolation width of 1.6 m/z). Singly and unassigned charge states were rejected. Dynamic exclusion was enabled with a repeat count of 1, an exclusion duration of 20 s, and an exclusion mass width of ±10 ppm.

Raw mass spectrometry data were assigned to S. cerevisiae protein sequences and MS1 intensities extracted with the MaxQuant software package (version 1.5.5.1) (Cox and Mann, 2008). Data were searched against the SwissProt S. cerevisiae protein database. Variable modifications were allowed for N-terminal protein acetylation, methionine oxidation, and lysine diglycine modification. A static modification was indicated for carbamidomethyl cysteine. The ‘Match between runs’ feature was enabled to match within 2 min between runs. All other settings were left using MaxQuant default settings.

Cell cycle and half-life analysis experiments

Overnight cultures grown at room temperature were diluted to OD600 of 0.25, and then arrested with 15 μg/mL alpha factor at room temperature for 4 hr. More alpha factor was added every 2 hr. To release cells from arrest, cells were washed and resuspended in fresh media, then shifted to 30°C. Small samples were taken for flow cytometry analysis. Alpha factor was added to cultures 45 min after release to prevent cells from re-entering the cell cycle following mitosis. For experiments analyzing the half-life of proteins, cycloheximide was added to cultures at 200 μg/mL at the indicated time points. For experiments analyzing the half-life of proteins in G1-arrested cultures, cells growing in YM-1 media with 2% raffinose were arrested in G1 phase as described above. Cells were then collected by centrifugation, washed and resuspended in YM-1 media containing 4% galactose and 15 μg/mL alpha factor for 1.5 hr, and shifted to 37°C. Cultures were then centrifuged and cells were resuspended in YM-1 containing 2% glucose, and 200 μg/mL cycloheximide. Cell pellets were collected by centrifugation at the indicated time points, washed with cold water, and then flash frozen. For flow cytometry analysis, cells were fixed in 70% ethanol, then treated at 50°C with RNase A (0.25 mg/mL in 50 mM sodium citrate) and Proteinase K (0.063 mg/mL in 50 mM sodium citrate) for 1 hr each, followed by incubation with Sytox Green (1:10,000) overnight at 4°C.

Western blots and antibodies

Cell pellets were resuspended in 100 μl of Sina’s loading buffer (50 mM Tris pH7.5, 5 mM EDTA, 10% glycerol, 5% SDS, 0.5% 2-mercaptoethanol, 0.1% w/v bromophenol blue) and 50 μl of glass beads. Samples were incubated at 100°C for 7 min, then processed in bead beater from 3 min, followed by heating at 100°C for 7 min. Cell lysates were analyzed by SDS-PAGE using 4–20% gradient Tis-HCl gels (BioRad, #3450034). Proteins were transferred onto 0.2-μm nitrocellulose membrane. Membranes were blocked with 5% nonfat dry milk in PBS-T or Odyssey Blocking Buffer. Rabbit antibodies recognizing Clb2, Clb3, Clb5, and Pds1 were generous gifts from Adam Rudner. Cdc28 was analyzed with goat antibody from Santa Cruz Biotechnology (yC-20). Mouse anti-PSTAIR (P7962) and Flag epitope (F3165) were purchased from Millipore-Sigma. Rabbit anti-ubiquitin antibody was purchased from Thermo-Fisher (PA3-16717) or Santa Cruz Biotechnology (sc-9133).

In vitro APC ubiquitination assay

APC was immunopurified using rabbit IgG beads (Invitogen 14301) from a yeast strain expressing Cdc16-TAP::HIS3 and lacking Cdh1 (cdh1::LEU2) in lysis buffer (25 mM HEPES 7.5, 150 mM KOAc, 5 mM MgCl2, 10% Glycerol, 0.2% Triton X, 1 mM DTT, 1 mM PMSF) for 1.5 hr at 4°C following bead beating. Beads were washed 3X with 25 mM HEPES 7.5, 150 mM KOAc, 10% Glycerol, 0.1% Triton X.

Cdh1 was in vitro translated using Promega kit (Promega L1170). Cdh1 was then incubated with the APC on beads from the above step for 30 min at room temperature. Beads were washed 3X with 25 mM HEPES 7.5, 150 mM KOAc, 10% Glycerol, 0.1% Triton X.

Hsl1 (667-872)-TAP was in vitro translated using Promega kit (Promega L1170) using 35S-Methionine. After in vitro translation, the Hsl1 fragment was incubated with IgG-coupled magnetic beads for 30 min, and washed 3X with 25 mM HEPES 7.5, 150 mM KOAc, 10% Glycerol, 0.1% Triton X. Hsl1 was cleaved off the beads with TEV protease for 30 min (AcTEV - Thermo Fisher 12575015).

Wild type (U-100Sc), K11-only (UM-K110) and K0 (UM-KOK) ubiquitin was purchased from Boston Biochem, INC. Uba1 and Ubc4 were expressed in E. coli and purified. Ubc4 was charged with ubiquitin using 0.2 mg/mL Uba1, 2 mg/mL Ubc4, 2 mg/mL ATP, and 2 mg/mL ubiquitin. The reaction was incubated at 37°C for at least 30 min.

APC-Cdh1 was incubated with charged Ubc4 and TEV purified Hsl1 fragment at 25°C for 45 min. Reactions were terminated by adding 2X SDS loading dye and analyzed by SDS-PAGE.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

David P Toczyski, Email: dpt4darwin@gmail.com.

Michael Rape, University of California, Berkeley, United States.

Ivan Dikic, Goethe University Frankfurt, Germany.

Funding Information

This paper was supported by the following grant:

  • National Institutes of Health R35 GM118104 to David P Toczyski.

Additional information

Competing interests

No competing interests declared.

is affiliated with Amgen Research. The author has no other competing interests to declare.

Author contributions

Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing.

Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—review and editing.

Validation, Investigation, Methodology.

Resources, Validation.

Formal analysis, Validation, Visualization, Methodology.

Formal analysis, Validation, Investigation, Methodology.

Investigation, Methodology.

Data curation, Formal analysis, Methodology.

Resources, Validation.

Resources, Investigation, Methodology.

Resources, Investigation, Methodology.

Resources, Investigation, Methodology.

Conceptualization, Supervision, Methodology, Project administration.

Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Project administration, Writing—review and editing.

Additional files

Supplementary file 1. Plasmids used in this study.
elife-42955-supp1.xlsx (43.4KB, xlsx)
DOI: 10.7554/eLife.42955.014
Supplementary file 2. Strains used in this study.
elife-42955-supp2.xlsx (51.4KB, xlsx)
DOI: 10.7554/eLife.42955.015
Supplementary file 3. Oligonucleotides used in this study.
elife-42955-supp3.xlsx (51.6KB, xlsx)
DOI: 10.7554/eLife.42955.016
Supplementary file 4. The full Ubiquitin SGA dataset.
elife-42955-supp4.xlsx (524.3KB, xlsx)
DOI: 10.7554/eLife.42955.017
Supplementary file 5. Quantitative proteomics analysis of the ubiquitinome in doa10Δ, ubc6Δ, ubc7Δ, ubc6,7Δ.
elife-42955-supp5.xlsx (57MB, xlsx)
DOI: 10.7554/eLife.42955.018
Transparent reporting form
DOI: 10.7554/eLife.42955.019

Data availability

All datasets generated are included as Supplementary Files 4 (SGA dataset) and 5 (quantitative proteomics).

References

  1. Akutsu M, Dikic I, Bremm A. Ubiquitin chain diversity at a glance. Journal of Cell Science. 2016;129:875–880. doi: 10.1242/jcs.183954. [DOI] [PubMed] [Google Scholar]
  2. Arlt H, Perz A, Ungermann C. An overexpression screen in Saccharomyces cerevisiae identifies novel genes that affect endocytic protein trafficking. Traffic. 2011;12:1592–1603. doi: 10.1111/j.1600-0854.2011.01252.x. [DOI] [PubMed] [Google Scholar]
  3. Arnason T, Ellison MJ. Stress resistance in Saccharomyces cerevisiae is strongly correlated with assembly of a novel type of multiubiquitin chain. Molecular and Cellular Biology. 1994;14:7876–7883. doi: 10.1128/MCB.14.12.7876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ben-Ari G, Zenvirth D, Sherman A, David L, Klutstein M, Lavi U, Hillel J, Simchen G. Four linked genes participate in controlling sporulation efficiency in budding yeast. PLOS Genetics. 2006;2:e195. doi: 10.1371/journal.pgen.0020195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Birsa N, Norkett R, Wauer T, Mevissen TE, Wu HC, Foltynie T, Bhatia K, Hirst WD, Komander D, Plun-Favreau H, Kittler JT. Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase. Journal of Biological Chemistry. 2014;289:14569–14582. doi: 10.1074/jbc.M114.563031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boeke JD, LaCroute F, Fink GR. A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Molecular and General Genetics MGG. 1984;197:345–346. doi: 10.1007/BF00330984. [DOI] [PubMed] [Google Scholar]
  7. Borg NA, Dixit VM. Ubiquitin in Cell-Cycle Regulation and Dysregulation in Cancer. Annual Review of Cancer Biology. 2017;1:59–77. doi: 10.1146/annurev-cancerbio-040716-075607. [DOI] [Google Scholar]
  8. Braberg H, Jin H, Moehle EA, Chan YA, Wang S, Shales M, Benschop JJ, Morris JH, Qiu C, Hu F, Tang LK, Fraser JS, Holstege FC, Hieter P, Guthrie C, Kaplan CD, Krogan NJ. From structure to systems: high-resolution, quantitative genetic analysis of RNA polymerase II. Cell. 2013;154:775–788. doi: 10.1016/j.cell.2013.07.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Briand JF, Navarro F, Rematier P, Boschiero C, Labarre S, Werner M, Shpakovski GV, Thuriaux P. Partners of Rpb8p, a small subunit shared by yeast RNA polymerases I, II and III. Molecular and Cellular Biology. 2001;21:6056–6065. doi: 10.1128/MCB.21.17.6056-6065.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Broemer M, Meier P. Ubiquitin-mediated regulation of apoptosis. Trends in Cell Biology. 2009;19:130–140. doi: 10.1016/j.tcb.2009.01.004. [DOI] [PubMed] [Google Scholar]
  11. Brown NG, VanderLinden R, Watson ER, Weissmann F, Ordureau A, Wu KP, Zhang W, Yu S, Mercredi PY, Harrison JS, Davidson IF, Qiao R, Lu Y, Dube P, Brunner MR, Grace CRR, Miller DJ, Haselbach D, Jarvis MA, Yamaguchi M, Yanishevski D, Petzold G, Sidhu SS, Kuhlman B, Kirschner MW, Harper JW, Peters JM, Stark H, Schulman BA. Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/C. Cell. 2016;165:1440–1453. doi: 10.1016/j.cell.2016.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carrano AC, Bennett EJ. Using the ubiquitin-modified proteome to monitor protein homeostasis function. Molecular & Cellular Proteomics. 2013;12:3521–3531. doi: 10.1074/mcp.R113.029744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK, Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science. 1989;243:1576–1583. doi: 10.1126/science.2538923. [DOI] [PubMed] [Google Scholar]
  14. Christensen DE, Brzovic PS, Klevit RE. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nature Structural & Molecular Biology. 2007;14:941–948. doi: 10.1038/nsmb1295. [DOI] [PubMed] [Google Scholar]
  15. Collins SR, Schuldiner M, Krogan NJ, Weissman JS. A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biology. 2006;7:R63. doi: 10.1186/gb-2006-7-7-r63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Collins SR, Miller KM, Maas NL, Roguev A, Fillingham J, Chu CS, Schuldiner M, Gebbia M, Recht J, Shales M, Ding H, Xu H, Han J, Ingvarsdottir K, Cheng B, Andrews B, Boone C, Berger SL, Hieter P, Zhang Z, Brown GW, Ingles CJ, Emili A, Allis CD, Toczyski DP, Weissman JS, Greenblatt JF, Krogan NJ. Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature. 2007;446:806–810. doi: 10.1038/nature05649. [DOI] [PubMed] [Google Scholar]
  17. Collins SR, Roguev A, Krogan NJ. Quantitative genetic interaction mapping using the E-MAP approach. Methods in Enzymology. 2010;470:205–231. doi: 10.1016/S0076-6879(10)70009-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, Toufighi K, Mostafavi S, Prinz J, St Onge RP, VanderSluis B, Makhnevych T, Vizeacoumar FJ, Alizadeh S, Bahr S, Brost RL, Chen Y, Cokol M, Deshpande R, Li Z, Lin ZY, Liang W, Marback M, Paw J, San Luis BJ, Shuteriqi E, Tong AH, van Dyk N, Wallace IM, Whitney JA, Weirauch MT, Zhong G, Zhu H, Houry WA, Brudno M, Ragibizadeh S, Papp B, Pál C, Roth FP, Giaever G, Nislow C, Troyanskaya OG, Bussey H, Bader GD, Gingras AC, Morris QD, Kim PM, Kaiser CA, Myers CL, Andrews BJ, Boone C. The genetic landscape of a cell. Science. 2010;327:425–431. doi: 10.1126/science.1180823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Costanzo M, VanderSluis B, Koch EN, Baryshnikova A, Pons C, Tan G, Wang W, Usaj M, Hanchard J, Lee SD, Pelechano V, Styles EB, Billmann M, van Leeuwen J, van Dyk N, Lin ZY, Kuzmin E, Nelson J, Piotrowski JS, Srikumar T, Bahr S, Chen Y, Deshpande R, Kurat CF, Li SC, Li Z, Usaj MM, Okada H, Pascoe N, San Luis BJ, Sharifpoor S, Shuteriqi E, Simpkins SW, Snider J, Suresh HG, Tan Y, Zhu H, Malod-Dognin N, Janjic V, Przulj N, Troyanskaya OG, Stagljar I, Xia T, Ohya Y, Gingras AC, Raught B, Boutros M, Steinmetz LM, Moore CL, Rosebrock AP, Caudy AA, Myers CL, Andrews B, Boone C. A global genetic interaction network maps a wiring diagram of cellular function. Science. 2016;353:aaf1420. doi: 10.1126/science.aaf1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology. 2008;26:1367–1372. doi: 10.1038/nbt.1511. [DOI] [PubMed] [Google Scholar]
  21. Dammer EB, Na CH, Xu P, Seyfried NT, Duong DM, Cheng D, Gearing M, Rees H, Lah JJ, Levey AI, Rush J, Peng J. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. Journal of Biological Chemistry. 2011;286:10457–10465. doi: 10.1074/jbc.M110.149633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Datta AB, Hura GL, Wolberger C. The structure and conformation of Lys63-linked tetraubiquitin. Journal of Molecular Biology. 2009;392:1117–1124. doi: 10.1016/j.jmb.2009.07.090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Delbecq P, Calvo O, Filipkowski RK, Piérard A, Messenguy F. Functional analysis of the leader peptide of the yeast gene CPA1 and heterologous regulation by other fungal peptides. Current Genetics. 2000;38:105–112. doi: 10.1007/s002940000140. [DOI] [PubMed] [Google Scholar]
  24. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103:351–361. doi: 10.1016/S0092-8674(00)00126-4. [DOI] [PubMed] [Google Scholar]
  25. Deutschbauer AM, Davis RW. Quantitative trait loci mapped to single-nucleotide resolution in yeast. Nature Genetics. 2005;37:1333–1340. doi: 10.1038/ng1674. [DOI] [PubMed] [Google Scholar]
  26. Dixon SJ, Costanzo M, Baryshnikova A, Andrews B, Boone C. Systematic mapping of genetic interaction networks. Annual Review of Genetics. 2009;43:601–625. doi: 10.1146/annurev.genet.39.073003.114751. [DOI] [PubMed] [Google Scholar]
  27. Elia AE, Boardman AP, Wang DC, Huttlin EL, Everley RA, Dephoure N, Zhou C, Koren I, Gygi SP, Elledge SJ. Quantitative proteomic atlas of ubiquitination and acetylation in the dna damage response. Molecular Cell. 2015;59:867–881. doi: 10.1016/j.molcel.2015.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Finley D, Bartel B, Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature. 1989;338:394–401. doi: 10.1038/338394a0. [DOI] [PubMed] [Google Scholar]
  29. Finley D, Sadis S, Monia BP, Boucher P, Ecker DJ, Crooke ST, Chau V. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Molecular and Cellular Biology. 1994;14:5501–5509. doi: 10.1128/MCB.14.8.5501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Finley D, Ulrich HD, Sommer T, Kaiser P. The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics. 2012;192:319–360. doi: 10.1534/genetics.112.140467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fisk DG, Ball CA, Dolinski K, Engel SR, Hong EL, Issel-Tarver L, Schwartz K, Sethuraman A, Botstein D, Cherry JM, Saccharomyces Genome Database Project Saccharomyces cerevisiae S288C genome annotation: a working hypothesis. Yeast. 2006;23:857–865. doi: 10.1002/yea.1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Foe IT, Foster SA, Cheung SK, DeLuca SZ, Morgan DO, Toczyski DP. Ubiquitination of Cdc20 by the APC occurs through an intramolecular mechanism. Current Biology. 2011;21:1870–1877. doi: 10.1016/j.cub.2011.09.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Garnett MJ, Mansfeld J, Godwin C, Matsusaka T, Wu J, Russell P, Pines J, Venkitaraman AR. UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nature Cell Biology. 2009;11:1363–1369. doi: 10.1038/ncb1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology. 2010;12:119–131. doi: 10.1038/ncb2012. [DOI] [PubMed] [Google Scholar]
  35. Geng F, Wenzel S, Tansey WP. Ubiquitin and proteasomes in transcription. Annual Review of Biochemistry. 2012;81:177–201. doi: 10.1146/annurev-biochem-052110-120012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Grabbe C, Husnjak K, Dikic I. The spatial and temporal organization of ubiquitin networks. Nature Reviews Molecular Cell Biology. 2011;12:295–307. doi: 10.1038/nrm3099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Haber JE, Braberg H, Wu Q, Alexander R, Haase J, Ryan C, Lipkin-Moore Z, Franks-Skiba KE, Johnson T, Shales M, Lenstra TL, Holstege FC, Johnson JR, Bloom K, Krogan NJ. Systematic triple-mutant analysis uncovers functional connectivity between pathways involved in chromosome regulation. Cell Reports. 2013;3:2168–2178. doi: 10.1016/j.celrep.2013.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hanna J, Leggett DS, Finley D. Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Molecular and Cellular Biology. 2003;23:9251–9261. doi: 10.1128/MCB.23.24.9251-9261.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Harper JW, Elledge SJ. The DNA damage response: ten years after. Molecular Cell. 2007;28:739–745. doi: 10.1016/j.molcel.2007.11.015. [DOI] [PubMed] [Google Scholar]
  40. Hashash N, Johnson AL, Cha RS. Regulation of fragile sites expression in budding yeast by MEC1, RRM3 and hydroxyurea. Journal of Cell Science. 2011;124:181–185. doi: 10.1242/jcs.077313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hashash N, Johnson AL, Cha RS. Topoisomerase II- and condensin-dependent breakage of MEC1ATR-sensitive fragile sites occurs independently of spindle tension, anaphase, or cytokinesis. PLOS Genetics. 2012;8:e1002978. doi: 10.1371/journal.pgen.1002978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hershko A, Ciechanover A. The ubiquitin system. Annual Review of Biochemistry. 1998;67:425–479. doi: 10.1146/annurev.biochem.67.1.425. [DOI] [PubMed] [Google Scholar]
  43. Huang daW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols. 2009a;4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
  44. Huang daW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research. 2009b;37:1–13. doi: 10.1093/nar/gkn923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Jackson SP, Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Molecular Cell. 2013;49:795–807. doi: 10.1016/j.molcel.2013.01.017. [DOI] [PubMed] [Google Scholar]
  46. Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell. 2008;133:653–665. doi: 10.1016/j.cell.2008.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kim HC, Huibregtse JM. Polyubiquitination by HECT E3s and the determinants of chain type specificity. Molecular and Cellular Biology. 2009;29:3307–3318. doi: 10.1128/MCB.00240-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kirkpatrick DS, Hathaway NA, Hanna J, Elsasser S, Rush J, Finley D, King RW, Gygi SP. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nature Cell Biology. 2006;8:700–710. doi: 10.1038/ncb1436. [DOI] [PubMed] [Google Scholar]
  49. Knauer R, Lehle L. The oligosaccharyltransferase complex from Saccharomyces cerevisiae. Isolation of the OST6 gene, its synthetic interaction with OST3, and analysis of the native complex. The Journal of Biological Chemistry. 1999;274:17249–17256. doi: 10.1074/jbc.274.24.17249. [DOI] [PubMed] [Google Scholar]
  50. Komander D, Rape M. The ubiquitin code. Annual Review of Biochemistry. 2012;81:203–229. doi: 10.1146/annurev-biochem-060310-170328. [DOI] [PubMed] [Google Scholar]
  51. Krogan NJ, Greenblatt JF. Characterization of a six-subunit holo-elongator complex required for the regulated expression of a group of genes in Saccharomyces cerevisiae. Molecular and Cellular Biology. 2001;21:8203–8212. doi: 10.1128/MCB.21.23.8203-8212.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lauwers E, Jacob C, André B. K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway. The Journal of Cell Biology. 2009;185:493–502. doi: 10.1083/jcb.200810114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Lauwers E, Erpapazoglou Z, Haguenauer-Tsapis R, André B. The ubiquitin code of yeast permease trafficking. Trends in Cell Biology. 2010;20:196–204. doi: 10.1016/j.tcb.2010.01.004. [DOI] [PubMed] [Google Scholar]
  54. Liu JQ, Nagata S, Dairi T, Misono H, Shimizu S, Yamada H. The GLY1 gene of Saccharomyces cerevisiae encodes a low-specific L-threonine aldolase that catalyzes cleavage of L-allo-threonine and L-threonine to glycine--expression of the gene in Escherichia coli and purification and characterization of the enzyme. European Journal of Biochemistry. 1997;245:289–293. doi: 10.1111/j.1432-1033.1997.00289.x. [DOI] [PubMed] [Google Scholar]
  55. Ljungdahl PO. Amino-acid-induced signalling via the SPS-sensing pathway in yeast. Biochemical Society Transactions. 2009;37:242–247. doi: 10.1042/BST0370242. [DOI] [PubMed] [Google Scholar]
  56. MacGurn JA, Hsu PC, Emr SD. Ubiquitin and membrane protein turnover: from cradle to grave. Annual Review of Biochemistry. 2012;81:231–259. doi: 10.1146/annurev-biochem-060210-093619. [DOI] [PubMed] [Google Scholar]
  57. Maeda T. The signaling mechanism of ambient pH sensing and adaptation in yeast and fungi. FEBS Journal. 2012;279:1407–1413. doi: 10.1111/j.1742-4658.2012.08548.x. [DOI] [PubMed] [Google Scholar]
  58. Manzanillo PS, Ayres JS, Watson RO, Collins AC, Souza G, Rae CS, Schneider DS, Nakamura K, Shiloh MU, Cox JS. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature. 2013;501:512–516. doi: 10.1038/nature12566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Matsumoto ML, Wickliffe KE, Dong KC, Yu C, Bosanac I, Bustos D, Phu L, Kirkpatrick DS, Hymowitz SG, Rape M, Kelley RF, Dixit VM. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Molecular Cell. 2010;39:477–484. doi: 10.1016/j.molcel.2010.07.001. [DOI] [PubMed] [Google Scholar]
  60. Meyer HJ, Rape M. Enhanced protein degradation by branched ubiquitin chains. Cell. 2014;157:910–921. doi: 10.1016/j.cell.2014.03.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mountain HA, Byström AS, Larsen JT, Korch C. Four major transcriptional responses in the methionine/threonine biosynthetic pathway of Saccharomyces cerevisiae. Yeast. 1991;7:781–803. doi: 10.1002/yea.320070804. [DOI] [PubMed] [Google Scholar]
  62. Neiman AM. Sporulation in the budding yeast Saccharomyces cerevisiae. Genetics. 2011;189:737–765. doi: 10.1534/genetics.111.127126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukuda M, Ohta T. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase. Journal of Biological Chemistry. 2004;279:3916–3924. doi: 10.1074/jbc.M308540200. [DOI] [PubMed] [Google Scholar]
  64. Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP, Sviderskiy VO, Olszewski JL, Koerber JT, Xie T, Beausoleil SA, Wells JA, Gygi SP, Schulman BA, Harper JW. Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Molecular Cell. 2014;56:360–375. doi: 10.1016/j.molcel.2014.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Ordureau A, Heo JM, Duda DM, Paulo JA, Olszewski JL, Yanishevski D, Rinehart J, Schulman BA, Harper JW. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. PNAS. 2015;112:6637–6642. doi: 10.1073/pnas.1506593112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ostapenko D, Burton JL, Solomon MJ. The Ubp15 deubiquitinase promotes timely entry into S phase in Saccharomyces cerevisiae. Molecular Biology of the Cell. 2015;26:2205–2216. doi: 10.1091/mbc.E14-09-1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Ozkaynak E, Finley D, Solomon MJ, Varshavsky A. The yeast ubiquitin genes: a family of natural gene fusions. The EMBO Journal. 1987;6:1429–1439. doi: 10.1002/j.1460-2075.1987.tb02384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Partow S, Siewers V, Bjørn S, Nielsen J, Maury J. Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae. Yeast. 2010;27:955–964. doi: 10.1002/yea.1806. [DOI] [PubMed] [Google Scholar]
  69. Petrakis TG, Søgaard TM, Erdjument-Bromage H, Tempst P, Svejstrup JQ. Physical and functional interaction between Elongator and the chromatin-associated Kti12 protein. Journal of Biological Chemistry. 2005;280:19454–19460. doi: 10.1074/jbc.M413373200. [DOI] [PubMed] [Google Scholar]
  70. Petroski MD, Deshaies RJ. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell. 2005;123:1107–1120. doi: 10.1016/j.cell.2005.09.033. [DOI] [PubMed] [Google Scholar]
  71. Rando OJ, Winston F. Chromatin and transcription in yeast. Genetics. 2012;190:351–387. doi: 10.1534/genetics.111.132266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Regenberg B, Düring-Olsen L, Kielland-Brandt MC, Holmberg S. Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae. Current Genetics. 1999;36:317–328. doi: 10.1007/s002940050506. [DOI] [PubMed] [Google Scholar]
  73. Rodrigo-Brenni MC, Foster SA, Morgan DO. Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. Molecular Cell. 2010;39:548–559. doi: 10.1016/j.molcel.2010.07.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Rodrigo-Brenni MC, Morgan DO. Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell. 2007;130:127–139. doi: 10.1016/j.cell.2007.05.027. [DOI] [PubMed] [Google Scholar]
  75. Ryan CJ, Roguev A, Patrick K, Xu J, Jahari H, Tong Z, Beltrao P, Shales M, Qu H, Collins SR, Kliegman JI, Jiang L, Kuo D, Tosti E, Kim HS, Edelmann W, Keogh MC, Greene D, Tang C, Cunningham P, Shokat KM, Cagney G, Svensson JP, Guthrie C, Espenshade PJ, Ideker T, Krogan NJ. Hierarchical modularity and the evolution of genetic interactomes across species. Molecular Cell. 2012;46:691–704. doi: 10.1016/j.molcel.2012.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sarin S, Ross KE, Boucher L, Green Y, Tyers M, Cohen-Fix O. Uncovering novel cell cycle players through the inactivation of securin in budding yeast. Genetics. 2004;168:1763–1771. doi: 10.1534/genetics.104.029033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Schuldiner M, Collins SR, Thompson NJ, Denic V, Bhamidipati A, Punna T, Ihmels J, Andrews B, Boone C, Greenblatt JF, Weissman JS, Krogan NJ. Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell. 2005;123:507–519. doi: 10.1016/j.cell.2005.08.031. [DOI] [PubMed] [Google Scholar]
  78. Schuldiner M, Collins SR, Weissman JS, Krogan NJ. Quantitative genetic analysis in Saccharomyces cerevisiae using epistatic miniarray profiles (E-MAPs) and its application to chromatin functions. Methods. 2006;40:344–352. doi: 10.1016/j.ymeth.2006.07.034. [DOI] [PubMed] [Google Scholar]
  79. Schwickart M, Havlis J, Habermann B, Bogdanova A, Camasses A, Oelschlaegel T, Shevchenko A, Zachariae W. Swm1/Apc13 is an evolutionarily conserved subunit of the anaphase-promoting complex stabilizing the association of Cdc16 and Cdc27. Molecular and Cellular Biology. 2004;24:3562–3576. doi: 10.1128/MCB.24.8.3562-3576.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Shirayama M, Tóth A, Gálová M, Nasmyth K. APC(Cdc20) promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature. 1999;402:203–207. doi: 10.1038/46080. [DOI] [PubMed] [Google Scholar]
  81. Sibirny AA. structure Yeast peroxisomes: functions and biotechnological opportunities. FEMS Yeast Research. 2016;16 doi: 10.1093/femsyr/fow038. [DOI] [PubMed] [Google Scholar]
  82. Silva GM, Finley D, Vogel C. K63 polyubiquitination is a new modulator of the oxidative stress response. Nature Structural & Molecular Biology. 2015;22:116–123. doi: 10.1038/nsmb.2955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Song EJ, Werner SL, Neubauer J, Stegmeier F, Aspden J, Rio D, Harper JW, Elledge SJ, Kirschner MW, Rape M. The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes & Development. 2010;24:1434–1447. doi: 10.1101/gad.1925010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Spence J, Sadis S, Haas AL, Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Molecular and Cellular Biology. 1995;15:1265–1273. doi: 10.1128/MCB.15.3.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Stagljar I, te Heesen S, Aebi M. New phenotype of mutations deficient in glucosylation of the lipid-linked oligosaccharide: cloning of the ALG8 locus. PNAS. 1994;91:5977–5981. doi: 10.1073/pnas.91.13.5977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Sumara I, Maerki S, Peter M. E3 ubiquitin ligases and mitosis: embracing the complexity. Trends in Cell Biology. 2008;18:84–94. doi: 10.1016/j.tcb.2007.12.001. [DOI] [PubMed] [Google Scholar]
  87. Swatek KN, Komander D. Ubiquitin modifications. Cell Research. 2016;26:399–422. doi: 10.1038/cr.2016.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Thornton BR, Toczyski DP, Securin TDP. Securin and B-cyclin/CDK are the only essential targets of the APC. Nature Cell Biology. 2003;5:1090–1094. doi: 10.1038/ncb1066. [DOI] [PubMed] [Google Scholar]
  89. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Pagé N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H, Andrews B, Tyers M, Boone C. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 2001;294:2364–2368. doi: 10.1126/science.1065810. [DOI] [PubMed] [Google Scholar]
  90. Tong AH, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, Chang M, Chen Y, Cheng X, Chua G, Friesen H, Goldberg DS, Haynes J, Humphries C, He G, Hussein S, Ke L, Krogan N, Li Z, Levinson JN, Lu H, Ménard P, Munyana C, Parsons AB, Ryan O, Tonikian R, Roberts T, Sdicu AM, Shapiro J, Sheikh B, Suter B, Wong SL, Zhang LV, Zhu H, Burd CG, Munro S, Sander C, Rine J, Greenblatt J, Peter M, Bretscher A, Bell G, Roth FP, Brown GW, Andrews B, Bussey H, Boone C. Global mapping of the yeast genetic interaction network. Science. 2004;303:808–813. doi: 10.1126/science.1091317. [DOI] [PubMed] [Google Scholar]
  91. Tong AHY, Boone C. Synthetic genetic array analysis in Saccharomyces cerevisiae. Methods Mol Biol Clifton NJ. 2006;313:171–192. doi: 10.1385/1-59259-958-3:171. [DOI] [PubMed] [Google Scholar]
  92. Tyers M, Jorgensen P. Proteolysis and the cell cycle: with this RING I do thee destroy. Current Opinion in Genetics & Development. 2000;10:54–64. doi: 10.1016/S0959-437X(99)00049-0. [DOI] [PubMed] [Google Scholar]
  93. Ulrich HD. The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO. ChemBioChem. 2005;6:1735–1743. doi: 10.1002/cbic.200500139. [DOI] [PubMed] [Google Scholar]
  94. Waldherr M, Ragnini A, Jank B, Teply R, Wiesenberger G, Schweyen RJ. A multitude of suppressors of group II intron-splicing defects in yeast. Current Genetics. 1993;24:301–306. doi: 10.1007/BF00336780. [DOI] [PubMed] [Google Scholar]
  95. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412:346–351. doi: 10.1038/35085597. [DOI] [PubMed] [Google Scholar]
  96. Wang B, Elledge SJ. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. PNAS. 2007;104:20759–20763. doi: 10.1073/pnas.0710061104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Wertz IE, Dixit VM. Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harbor Perspectives in Biology. 2010;2:a003350. doi: 10.1101/cshperspect.a003350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Wickliffe KE, Lorenz S, Wemmer DE, Kuriyan J, Rape M. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell. 2011;144:769–781. doi: 10.1016/j.cell.2011.01.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Williamson A, Wickliffe KE, Mellone BG, Song L, Karpen GH, Rape M. Identification of a physiological E2 module for the human anaphase-promoting complex. PNAS. 2009;106:18213–18218. doi: 10.1073/pnas.0907887106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Wu T, Merbl Y, Huo Y, Gallop JL, Tzur A, Kirschner MW. UBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting Complex. PNAS. 2010;107:1355–1360. doi: 10.1073/pnas.0912802107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J, Hochstrasser M, Finley D, Peng J. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell. 2009;137:133–145. doi: 10.1016/j.cell.2009.01.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Yau RG, Doerner K, Castellanos ER, Haakonsen DL, Werner A, Wang N, Yang XW, Martinez-Martin N, Matsumoto ML, Dixit VM, Rape M. Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. Cell. 2017;171:918–933. doi: 10.1016/j.cell.2017.09.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Yuan WC, Lee YR, Lin SY, Chang LY, Tan YP, Hung CC, Kuo JC, Liu CH, Lin MY, Xu M, Chen ZJ, Chen RH. K33-Linked Polyubiquitination of Coronin 7 by Cul3-KLHL20 Ubiquitin E3 Ligase Regulates Protein Trafficking. Molecular Cell. 2014;54:586–600. doi: 10.1016/j.molcel.2014.03.035. [DOI] [PubMed] [Google Scholar]
  104. Zachariae W, Shevchenko A, Andrews PD, Ciosk R, Galova M, Stark MJ, Mann M, Nasmyth K. Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins. Science. 1998a;279:1216–1219. doi: 10.1126/science.279.5354.1216. [DOI] [PubMed] [Google Scholar]
  105. Zachariae W, Schwab M, Nasmyth K, Seufert W. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science. 1998b;282:1721–1724. doi: 10.1126/science.282.5394.1721. [DOI] [PubMed] [Google Scholar]
  106. Zattas D, Hochstrasser M. Ubiquitin-dependent protein degradation at the yeast endoplasmic reticulum and nuclear envelope. Critical Reviews in Biochemistry and Molecular Biology. 2015;50:1–17. doi: 10.3109/10409238.2014.959889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Zhang Z, Lv X, Yin WC, Zhang X, Feng J, Wu W, Hui CC, Zhang L, Zhao Y. Ter94 ATPase complex targets k11-linked ubiquitinated ci to proteasomes for partial degradation. Developmental Cell. 2013;25:636–644. doi: 10.1016/j.devcel.2013.05.006. [DOI] [PubMed] [Google Scholar]
  108. Zhou HL, Geng C, Luo G, Lou H. The p97-UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP. Genes & Development. 2013;27:1046–1058. doi: 10.1101/gad.215681.113. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: Michael Rape1
Reviewed by: Junmin Peng2

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

[Editors’ note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.]

Thank you for submitting your work entitled "Genetic Analysis Reveals Functions of Atypical Polyubiquitin Chains" for consideration by eLife. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in eLife.

While all reviewers noted the strength of the genetic screen you employed for discovering new functions of specific ubiquitin linkages, they also noted shortcomings. There was an agreement among the reviewers, particularly after careful discussion of both the paper and the reviews, that in its current state it is not clear whether the K11 function for threonine import is due to substrate modification with K11-linked chains or due to a distinct role of Lys11 of ubiquitin (as had been observed with other Lys residues that fulfill binding or recognition functions). This concern is in part due to a lack of biochemical follow-up of your genetic discoveries, which the reviewers considered to be essential. Finally, there was some concern about novelty of your findings in light of lack of more detailed mechanistic insight. As the experiments required by the reviewers (again after careful discussion among all reviewers) would take much longer than the 2-3 months usually accepted by eLife, we believe that your paper will find a better home in a different journal.

Reviewer #1:

The functional consequences of modification with ubiquitin chains of distinct topologies in cells remain ill-defined. To address this shortcoming, the authors of this paper developed a powerful synthetic genetic interaction platform testing for genetic interactions of six out of seven possible Lys-Arg ubiquitin modifications in yeast. As ubiquitin is encoded by four genes, this required the development of a new SGA library in SK1 yeast strains, an effort that will allow more complex genetic interaction studies to be conducted in the future. The results of their SGA screen provides a rich data-source with thousands of candidate interactions between gene deletions and specific ubiquitin Lys-Arg mutations; thus, these findings will be very interesting for a broad readership and could be a starting point for many new investigations. They validated two genetic interactions of K11R mutant yeast with enzymes of threonine biosynthesis and cell cycle regulation; in particular, their work on K11-ubiquitin dependent regulation of threonine import provides a new angle for K11-linked ubiquitin chains and thus underscores the potential of the chosen genetic approach. However, the authors were unable to provide mechanistic insight into the functions of K11 linkages in controlling threonine import, as the substrates as well as the nature of the modification (homotypic K11-linked chain versus more complex mixed or branched chains in which K11-linkages constitute only one out of several linkages) remain unknown.

Together, I am convinced that this manuscript provides rich data for many researchers that are interested in understanding functional consequences of ubiquitin chain modifications in cells. Given the lack of mechanistic insight, I would argue that this paper should be published as a Tools and Resources article, rather than a Research Article, after the following issues have been addressed.

1) Given that the SGA analysis is the main strength of the paper and will generate broad interest, I believe it is pivotal that the data can be interrogated in an easy, online manner. This could be achieved by providing a searchable database for genetic interactions observed in this study.

2) The stabilization phenotypes in Figure 4 are weak, i.e. as they are only observed in cells lacking CDC26. To provide a more solid foundation for these results, the degradation experiments in Figure 4B, C need to be repeated, quantified, and analyzed with appropriate statistical tools.

3) It is interesting that K11R mutants do not drive clustering, as opposed to other K-R mutants. A potential explanation for this could be that in yeast, K11-linkages are predominantly used for chain initiation, allowing for branching off of chain blocks that in turn determine the outcome of the modification. This would be consistent with their two examples (particularly with the APC/C, where K48-linkages are thought to provide the main degradation signal in yeast). The authors might want to discuss this possibility more explicitly.

Reviewer #2:

Protein ubiquitination plays a critical role in almost all cellular events. Diverse polyUb chains have been found to be commonly present in cells, and harbor different dynamic structures, although their abundance appears to be different, dependent on the total number and absolute levels of modified substrates. The Ub chains have been recognized to contribute to signaling specificity in Ub conjugation, recognition, de-conjugation, and functional consequences. Dissection of the function of these diverse polyUb modifications, however, is still technically challenging and largely limited to the studies of individual substrates. Meza-Gutierrez et al. attempted to explore physiological functions of individual polyUb chains by large-scale genetic interactions. Although the scope of the study was large, and the link of K11 chains to amino acid homeostasis and cell cycle regulation is reliable, there are some concerns with unknown false discovery rate, indirect consequence of genetic mutations, and lacking of solid biochemical analysis. Thus, as in current status, the manuscript may not be suitable for the publication in eLife, but is more appropriate for a specialized journal in genetics. Specific concerns are as follows:

1) In addition to 7 lysine residues, the N-terminal amine group is also involved in the assembly of polyUb chain, in particular in some immunological pathways in mammalian cells. Although N-terminal polyUb is not essential in yeast, shown in Dr. Dan Finely's genetics analysis with N-terminal tagged Ub, it may still be functional in specific pathways. This point is not mentioned in the Introduction, and is not considered during the genetics interaction assay.

2) As Ub K48 is essential for yeast growth, the authors generated a strain with K48R but maintaining 33% expression of wild type ubiquitin. The rationale for 33% is not well specified. What is the minimal level of wild type Ub required for the assay. In addition, K63R mutation was not used due to another technical issue.

3) It may be discussed that only non-essential gene deletions (n = 2,655) were used in this study. Another ~50% genes were not tested. It is not known if the 2,655 genes were expressed and well represented in the ubiquitinated proteome. Since multiple large-scale ubiquitinated studies were reported in yeast, it may be useful to examine whether the 2,655 proteins are ubiquitinated and unbiasedly detected in the ubiquitinated proteome.

4) In the last paragraph of the subsection “The ubiquitin linkage synthetic genetic array”, a small group of genetics interactions were validated in an independent analysis. It is important to estimate the false discovery rate of the initial genetic interaction analysis at the global level.

5) Subsequent genetic studies of K11 chains involved in amino acid homeostasis and mitotic progression are interesting and comprehensive, including the usage of numerous Hom2, Hom3 and Doa10 mutations, although the function of K11 in APC modification is well known in mammalian cells. The Thr pathway discovery is novel but not fully investigated by other complementary tools, such as biochemical or mass spectrometric approaches to identify potential targets, cell biology approaches to investigate potential protein distribution (sorting or internalization) defect in K11R mutation.

6) In addition, to make the discovery more appealing, it is ideal to address whether the K11 linkage functions to regulate amino acid homeostasis in mammalian cells.

Reviewer #3:

The manuscript by Meza-Gutierrez et al., describes an SGA screening strategy to uncover potential functions of specific ubiquitin linkages in the budding yeast. Using the output of their screen, the authors drill down on two of the promising genetic interactions uncovered, specifically the potential role of Lysine-11 linkages in threonine biosynthesis and in APC substrate turnover. While the experimental results overall validate that the discovered genetic links are real (not simply noise), the novelty of the discoveries and the lack of understanding of the underlying mechanism of action tempers this reviewer's enthusiasm.

The authors generated yeast haploids with individual and combinations of lysine-to-arginine mutations in each of three ubiquitin genes (plus deletion of the Ubl1 locus) and crossed/mated these to a haploid gene deletion array (also containing the Ubl1 deletion). Selection and high sporulation efficiency to generate haploids containing the ubiquitin mutation and non-essential gene deletion was accomplished in the SK1 yeast strain to reduce background from unsporulated diploid cells.

Growth of mutant strains was measured and clustered to identify genetic interactions. Known gene modules were identified by the clustering approach providing confidence in the process. (Figure 1B). A subset of hits (ubc4Δ, hom2Δ and cdc26Δ) were characterized in more detail (Figure 2) to demonstrate that the SGA screen results are reproducible and robust.

Two genetic interactions with the K11-Ubiquitin mutant were then chosen for further investigation, in part because K11-linkages are prevalent in yeast and their functional significance is poorly understood, and because of the proven importance of K11-linkages in metazoan biology.

First: The discovery of synthetic growth defects for HOM2 and HOM3 genes within the homoserine biosynthesis pathways suggested functional redundancy of K11-Ubiquitin linkages with amino acid homeostasis (Figure 3A-C). In support of this hypothesis, the growth defect of K11/hom2 and K11/hom3 double mutant strains were rescued by supplementation of homoserine or threonine but not methionine (Figure 3D).

The genetic interactome displayed by the K11R Ub linkage mutant was suggestively similar to that uncovered previously for GNP1, a threonine permease. To assess if K11-ubiquitin linkages serve a similar role to GNP1 in threonine import, the authors measured uptake of radioactive threonine for WT and K11R mutant strains in a time course experiment. In support of a role for K11 chains in Thr transport, the K11R mutant displayed almost a 2 fold lower transport (Figure 3F). Note that it would have been useful to show the relative effect of the gnp1Δ mutant for comparison.

Interestingly, the E3 ligase Doa10 responsible for the majority of K11-linked ubiquitin chains in yeast also showed a synthetic growth defect that could be rescued by homoserine (Figure 3G). This discovery is very important because it provides the first (and only?) corroborating piece of evidence to suggest that the loss of K11 ubiquitin chain linkages may actually underpin the detected genetic interaction. Up to this point in the manuscript, the authors have not ruled out the possibility (and still it remains possible) that the genetic interactions detected relate to the ability of the K11R mutation to affect some function of Ub beyond its ability to form K11 chains. For example, the K11 side chain of ubiquitin could be involved in a physiological protein-protein interaction that could not be faithfully mimicked by arginine.

This raises a major criticism of the paper – namely that until the full or minimally a major portion of the underlying mechanism of action of the K11R mutation for the process in question is figured out, there is no certainty that the working hypothesis of a role for specific chain linkage is correct.

Second: The authors then investigate the strong genetic interaction of the K11R Ub mutant with CDC26, a non-essential subunit of the APC. In Figure 4, the authors show that levels of a number of known APC substrates are affected by the K11R mutation including Clb1 and Pds1/securin most strongly and Clb3, and Clb5 to a lesser extent. The key question that remains to be addressed is whether the effects of the K11R mutation on these substrate levels are direct or indirect. Until the mechanism of the K11R mutation is fleshed out in more detail, one cannot say with any certainty. Since the role of K11 chains is well established for the metazoan APC, this fact lends some support to the notion that the K11 Ub linkage type could play a direct role in APC function in yeast. However, this point also has the effect of subtracting from the novelty of their discovery. The fact that K11R mutant has no effect on WT yeast also suggests that K11 linkages are not all that important to yeast biology.

Additional points:

1) It would be informative if the authors were to show FACS profiles for the analyses described in Figure 4.

2) The result of the Figure 4B would be more compelling if the authors were to include quantification of band intensities in Figure 4. Also include additional loading controls.

[Editors’ note: what now follows is the decision letter after the authors submitted for further consideration.]

Congratulations, we are pleased to inform you that your article, "Genetic Analysis Reveals Functions of Atypical Polyubiquitin Chains", has been accepted for publication in eLife.

This manuscript introduces an important genetic approach to dissect signaling through distinct ubiquitin chain topologies. It has used synthetic interaction screens to reveal novel functions of K11-linked chains in threonine important, as well as to provide an interesting new angle on the role of K11-linked chains in yeast cell cycle regulation. The technology is important and the screen results provide interesting starting points for many new projects, and hence, this manuscript should be distributed widely. However, the molecular insights coming out of the screen are still a bit less well developed, and this paper has to be published in the "Tools and Resources" format.

Reviewer #1:

The authors of this resubmitted manuscript addressed some of the initial concerns raised by all three reviewers. However, they did not identify a direct substrate for K11-specific ubiquitylation that plays a role in threonine import. The identification of K11-linkages in ubiquitin chains attached to APC-substrates in yeast has been validated biochemically, yet the architecture of the resulting conjugates has also not been addressed (as would have been expected given the known chain architecture of human APC). As I had mentioned during the first round of review, I therefore believe that this manuscript is worthwhile to be published in eLife as it provides a novel way to identify cellular functions of particular ubiquitin linkages; however, given the lack of molecular insight, I would argue this should be published as a Tools and Resources article, and not as a Research Article.

Reviewer #2:

All of my comments have been well addressed by additional experiments and discussion. The revised manuscript is significantly improved and acceptable for publication.

eLife. 2018 Dec 14;7:e42955. doi: 10.7554/eLife.42955.022

Author response


[Editors’ note: the author responses to the first round of peer review follow.]

While all reviewers noted the strength of the genetic screen you employed for discovering new functions of specific ubiquitin linkages, they also noted shortcomings. There was an agreement among the reviewers, particularly after careful discussion of both the paper and the reviews, that in its current state it is not clear whether the K11 function for threonine import is due to substrate modification with K11-linked chains or due to a distinct role of Lys11 of ubiquitin (as had been observed with other Lys residues that fulfill binding or recognition functions). This concern is in part due to a lack of biochemical follow-up of your genetic discoveries, which the reviewers considered to be essential. Finally, there was some concern about novelty of your findings in light of lack of more detailed mechanistic insight. As the experiments required by the reviewers (again after careful discussion among all reviewers) would take much longer than the 2-3 months usually accepted by eLife, we believe that your paper will find a better home in a different journal.

All reviewers coincided in their major criticism, namely a lack of biochemistry, leaving open the possibility that the amino acid import and APC-substrate turnover defects observed in K11R ubiquitin mutant cells are unrelated specifically to K11-linked polyubiquitin chains. As noted by reviewer 3, data showing that doa10Δ phenocopies the K11R result related to amino acid import “is very important because it provides the first (and only?) corroborating piece of evidence to suggest that the loss of K11 ubiquitin chain linkages may actually underpin the detected genetic interaction.” However, they note that our discovery of a “strong genetic interaction of the K11R Ub mutant with CDC26” and that “that levels of a number of known APC substrates are affected by the K11R mutation” could be indirect because “The key question that remains to be addressed is whether the effects of the K11R mutation on these substrate levels are direct or indirect. Until the mechanism of the K11R mutation is fleshed out in more detail, one cannot say with any certainty.” We took these criticisms to heart. In the case of DOA10, we performed SILAC mass spectrometry analysis, but were unable to identify substrates likely responsible for the phenotype (included in the supplement). However, as noted by the reviewer, the identification of DOA10 already provides significant corroboration. We therefore concentrated on our APC data.

We now show that the yeast APC and its cognate E2 enzyme, Ubc4, modify substrates with K11- linked polyubiquitin chains in vitro. This was carried out not only with a WT fragment of Hsl1, which has many lysine acceptors, but also a novel Hsl1 variant with only a single target lysine. These results clearly show that the E2 that generates base chains in yeast, Ubc4, adds K11 linked chains. When viewed in combination with direct alterations of substrate turnover rates in vivo and the synthetic growth phenotypes we reported in our original submission to eLife, our results provide strong and direct in vivo and in vitro evidence that polyubiquitination of APC substrates with K11-linked ubiquitin chains promotes their timely degradation, thereby contributing to normal cell cycle progression.

Importantly, our in vitro and molecular data suggest that, while K11 and K48 are the two critical linkages in both yeast and humans, the architecture of ubiquitin chains on APC substrates differs. In humans, K48 is thought to exist in the base chain, and these are extended with homogenous K11, whereas our data are consistent with yeast APC having a critical K11 linkage in the base chain, with a more homogenous K48 addition onto that. Thus, we have uncovered a related, but distinct role for this linkage in APC biology. This provides an interesting perspective on the evolutionary conservation of the APC: The linkages important for APC function are highly conserved, but the architecture in which they are employed is not.

Two reviewers of our manuscript requested a quantitative analysis of the representative western blot images presented in Figure 4, which show the delayed degradation of various APC substrates observed in K11R ubiquitin mutant cells. To address this criticism, we have now undertaken extensive efforts to quantify and normalize band intensities, and use these data to present precise half-lives in Figure 4.

We would like to point out that there is a long tradition in molecular biology of studying posttranslational modifications by examining mutants that eliminate phosphorylation or acetylation sites. While there will always be some chance that a single conservative mutation will cause a non-specific effect, this type of analysis is the very backbone of the kinase and HAT fields, and has provided tremendous insights into these fields. K11 has been shown to be present and abundant in vivo; we have found growth phenotypes associated with specific mutations; we have shown that the an E3 (Doa10) thought to generate such linkages has a similar phenotype; we have shown that APC activity is compromised in vivo; and we have now shown that the APC generates such linkages in vitro. We feel that this provides enormous support for our ability to identify functional roles of these linkages in vivo.

Reviewer #1:

The functional consequences of modification with ubiquitin chains of distinct topologies in cells remain ill-defined. To address this shortcoming, the authors of this paper developed a powerful synthetic genetic interaction platform testing for genetic interactions of six out of seven possible Lys-Arg ubiquitin modifications in yeast. As ubiquitin is encoded by four genes, this required the development of a new SGA library in SK1 yeast strains, an effort that will allow more complex genetic interaction studies to be conducted in the future. The results of their SGA screen provides a rich data-source with thousands of candidate interactions between gene deletions and specific ubiquitin Lys-Arg mutations; thus, these findings will be very interesting for a broad readership and could be a starting point for many new investigations. They validated two genetic interactions of K11R mutant yeast with enzymes of threonine biosynthesis and cell cycle regulation; in particular, their work on K11-ubiquitin dependent regulation of threonine import provides a new angle for K11-linked ubiquitin chains and thus underscores the potential of the chosen genetic approach. However, the authors were unable to provide mechanistic insight into the functions of K11 linkages in controlling threonine import, as the substrates as well as the nature of the modification (homotypic K11-linked chain versus more complex mixed or branched chains in which K11-linkages constitute only one out of several linkages) remain unknown.

Together, I am convinced that this manuscript provides rich data for many researchers that are interested in understanding functional consequences of ubiquitin chain modifications in cells. Given the lack of mechanistic insight, I would argue that this paper should be published as a Tools and Resources article, rather than a Research Article, after the following issues have been addressed.

We thank this reviewer for their interest in our manuscript. We have now made several modifications to quantify the data, as suggested. In addition, we have provided additional follow-up, which we hope the reviewer agrees provides more mechanistic insight. We should note that while we have maintained the manuscript as a Research Article, we would consider the Tools and Resources format, as suggested by the reviewer, if the editors feel this is the required.

1) Given that the SGA analysis is the main strength of the paper and will generate broad interest, I believe it is pivotal that the data can be interrogated in an easy, online manner. This could be achieved by providing a searchable database for genetic interactions observed in this study.

Supplementary file 4 includes the full ubiquitin SGA dataset formatted to be easily viewable using freely-available software tools. In particular, the authors recommend viewing the ubiquitin SGA as a heat map using Java TreeView, a free and user-friendly software that is compatible with the Windows, Macintosh, and Linux operating systems. Java TreeView can be downloaded from https://sourceforge.net/projects/jtreeview. This information is now provided in the manuscript.

2) The stabilization phenotypes in Figure 4 are weak, i.e. as they are only observed in cells lacking CDC26. To provide a more solid foundation for these results, the degradation experiments in Figure 4B, C need to be repeated, quantified, and analyzed with appropriate statistical tools.

As discussed above, we now report normalized, quantified band intensities in Figure 4.

3) It is interesting that K11R mutants do not drive clustering, as opposed to other K-R mutants. A potential explanation for this could be that in yeast, K11-linkages are predominantly used for chain initiation, allowing for branching off of chain blocks that in turn determine the outcome of the modification. This would be consistent with their two examples (particularly with the APC/C, where K48-linkages are thought to provide the main degradation signal in yeast). The authors might want to discuss this possibility more explicitly.

This is an interesting suggestion. In fact, our work suggests that to mediate APC-substrate degradation, K11 linkages function as chain initiators or anchors that are extended by long K48 chains, in contrast to the human APC. We now discuss this and include a model in Figure 4.

Reviewer #2:

Protein ubiquitination plays a critical role in almost all cellular events. Diverse polyUb chains have been found to be commonly present in cells, and harbor different dynamic structures, although their abundance appears to be different, dependent on the total number and absolute levels of modified substrates. The Ub chains have been recognized to contribute to signaling specificity in Ub conjugation, recognition, de-conjugation, and functional consequences. Dissection of the function of these diverse polyUb modifications, however, is still technically challenging and largely limited to the studies of individual substrates. Meza-Gutierrez et al. attempted to explore physiological functions of individual polyUb chains by large-scale genetic interactions. Although the scope of the study was large, and the link of K11 chains to amino acid homeostasis and cell cycle regulation is reliable, there are some concerns with unknown false discovery rate, indirect consequence of genetic mutations, and lacking of solid biochemical analysis. Thus, as in current status, the manuscript may not be suitable for the publication in eLife, but is more appropriate for a specialized journal in genetics. Specific concerns are as follows:

We have performed additional analyses to evaluate the robustness of the genetic interaction data, and have now included a biochemical analysis of K11 linkages and the APC, which we hope the reviewer feels strengthens the manuscript.

1) In addition to 7 lysine residues, the N-terminal amine group is also involved in the assembly of polyUb chain, in particular in some immunological pathways in mammalian cells. Although N-terminal polyUb is not essential in yeast, shown in Dr. Dan Finely's genetics analysis with N-terminal tagged Ub, it may still be functional in specific pathways. This point is not mentioned in the Introduction, and is not considered during the genetics interaction assay.

We thank the reviewer for pointing out this omission. We now mention this in the Introduction.

2) As Ub K48 is essential for yeast growth, the authors generated a strain with K48R but maintaining 33% expression of wild type ubiquitin. The rationale for 33% is not well specified. What is the minimal level of wild type Ub required for the assay. In addition, K63R mutation was not used due to another technical issue.

While the exact minimum level of wild type ubiquitin required to carry out the SGA analysis, or to permit S. cerevisiae cells to survive was not determined, the K48R ubiquitin mutants in our study, aside from genetic interaction data, provide interesting insights into ubiquitin biology. The classic model for proteasomal degradation for ubiquitinated proteins has held that the minimum signal for efficient proteasomal degradation is a K48-linked chain of at least 4 ubiquitins. Because the strains used in the SGA analysis express only 20% wild type ubiquitin, the high abundance of K48R ubiquitin likely results in frequent early termination of chains generated by K48-specific E2 and E3 enzymes. (Note, there was a miscalculation in the original manuscript, the K48 actually represents 80, not 66, percent of the ubiquitin.) Although the lack of obvious phenotypes related to widespread protein degradation defects is surprising, it is consistent with reports by Braten et al. (2016), Martinez-Fonts et al. (2016), and others, which have suggested that monoubiquitin as well as non-48 or K11-linked chains can promote proteasomal degradation in some cases.

3) It may be discussed that only non-essential gene deletions (n = 2,655) were used in this study. Another ~50% genes were not tested. It is not known if the 2,655 genes were expressed and well represented in the ubiquitinated proteome. Since multiple large-scale ubiquitinated studies were reported in yeast, it may be useful to examine whether the 2,655 proteins are ubiquitinated and unbiasedly detected in the ubiquitinated proteome.

Proteomics studies are continually increasing the number of known ubiquitination sites. However, the precise proportion of proteins that are modified by ubiquitin in yeast is unknown. Nonetheless, based on published datasets curated by the Saccharomyces cerevisiae Genome Database (SGD), approximately a third of the genes in the ubiquitin SGA have been reported as being ubiquitinated.

4) In the last paragraph of the subsection “The ubiquitin linkage synthetic genetic array”, a small group of genetics interactions were validated in an independent analysis. It is important to estimate the false discovery rate of the initial genetic interaction analysis at the global level.

We thank the reviewer for pointing out this omission. The ubiquitin SGA had a correlation coefficient between replicates that is similar to what has been observed with other large genetic interaction screens. We have included a scatter plot showing the correlation between replicates of the screen in Figure 1C. The genetic interactions shown in Figure 3 provide a striking example of the robustness of the SGA dataset. With spot dilution assays, we are able to detect strong genetic interactions identified by the screen, such as the synthetic interaction between HOM2/3 and K11 mutants, and several others shown in Figure 3. Significantly, weak genetic interactions are also reproducible, such as the mild synthetic interaction between CDC26 and K11 and K33 ubiquitin mutants. In addition, we have now carried out an analysis of the correlation between known physical interactions and genetic interactions in our screen. Similar to what is observed with other genetic screens, such as the chromosome biology E-MAP (Collins et al., 2007), we find that genes known to physically interact are more likely to have common genetic interactions in our screen, and thus their genetic interaction profiles are more highly correlated than those for genes that do not interact physically (see Figure 1D). These observations underscore the robustness of the ubiquitin SGA.

5) Subsequent genetic studies of K11 chains involved in amino acid homeostasis and mitotic progression are interesting and comprehensive, including the usage of numerous Hom2, Hom3 and Doa10 mutations, although the function of K11 in APC modification is well known in mammalian cells. The Thr pathway discovery is novel but not fully investigated by other complementary tools, such as biochemical or mass spectrometric approaches to identify potential targets, cell biology approaches to investigate potential protein distribution (sorting or internalization) defect in K11R mutation.

We appreciate this point and undertook significant effort on this front. Unpublished results show that the expression and distribution of Gnp1, a threonine transporter, are undisturbed by mutation of ubiquitin’s K11. We have also undertaken a SILAC experiment in doa10∆ versus WT cells to identify substrates that might be responsible for this phenotype, but likely candidates were not uncovered. However, we have characterized the role of K11 in the APC in some detail. Importantly, while it is related to its role in human cells, it appears distinct in that it suggests the use of K11 as a base chain of the reaction.

6) In addition, to make the discovery more appealing, it is ideal to address whether the K11 linkage functions to regulate amino acid homeostasis in mammalian cells.

While this suggestion by the reviewer 2 would certainly be a fascinating extension of our results, it is outside the scope of the present work.

Reviewer #3:

The manuscript by Meza-Gutierrez et al., describes an SGA screening strategy to uncover potential functions of specific ubiquitin linkages in the budding yeast. Using the output of their screen, the authors drill down on two of the promising genetic interactions uncovered, specifically the potential role of Lysine-11 linkages in threonine biosynthesis and in APC substrate turnover. While the experimental results overall validate that the discovered genetic links are real (not simply noise), the novelty of the discoveries and the lack of understanding of the underlying mechanism of action tempers this reviewer's enthusiasm.

The authors generated yeast haploids with individual and combinations of lysine-to-arginine mutations in each of three ubiquitin genes (plus deletion of the Ubl1 locus) and crossed/mated these to a haploid gene deletion array (also containing the Ubl1 deletion). Selection and high sporulation efficiency to generate haploids containing the ubiquitin mutation and non-essential gene deletion was accomplished in the SK1 yeast strain to reduce background from unsporulated diploid cells.

Growth of mutant strains was measured and clustered to identify genetic interactions. Known gene modules were identified by the clustering approach providing confidence in the process. (Figure 1B). A subset of hits (ubc4Δ, hom2Δ and cdc26Δ) were characterized in more detail (Figure 2) to demonstrate that the SGA screen results are reproducible and robust. Two genetic interactions with the K11-Ubiquitin mutant were then chosen for further investigation, in part because K11-linkages are prevalent in yeast and their functional significance is poorly understood, and because of the proven importance of K11-linkages in metazoan biology. First: The discovery of synthetic growth defects for HOM2 and HOM3 genes within the homoserine biosynthesis pathways suggested functional redundancy of K11-Ubiquitin linkages with amino acid homeostasis (Figure 3ABC). In support of this hypothesis, the growth defect of K11/Hom2 and K11/Hom3 double mutant strains were rescued by supplementation of homoserine or threonine but not methionine (Figure 3D). The genetic interactome displayed by the K11R Ub linkage mutant was suggestively similar to that uncovered previously for GNP1, a threonine permease. To assess if K11-ubiquitin linkages serve a similar role to GNP1 in threonine import, the authors measured uptake of radioactive threonine for WT and K11R mutant strains in a time course experiment. In support of a role for K11 chains in Thr transport, the K11R mutant displayed almost a 2 fold lower transport (Figure 3F). Note that it would have been useful to show the relative effect of the gnp1Δ mutant for comparison. Interestingly, the E3 ligase Doa10 responsible for the majority of K11-linked ubiquitin chains in yeast also showed a synthetic growth defect that could be rescued by homoserine (Figure 3G). This discovery is very important because it provides the first (and only?) corroborating piece of evidence to suggest that the loss of K11 ubiquitin chain linkages may actually underpin the detected genetic interaction. Up to this point in the manuscript, the authors have not ruled out the possibility (and still it remains possible) that the genetic interactions detected relate to the ability of the K11R mutation to affect some function of Ub beyond its ability to form K11 chains. For example, the K11 side chain of ubiquitin could be involved in a physiological protein-protein interaction that could not be faithfully mimicked by arginine. This raises a major criticism of the paper – namely that until the full or minimally a major portion of the underlying mechanism of action of the K11R mutation for the process in question is figured out, there is no certainty that the working hypothesis of a role for specific chain linkage is correct. Second: The authors then investigate the strong genetic interaction of the K11R Ub mutant with CDC26, a non-essential subunit of the APC. In Figure 4, the authors show that levels of a number of known APC substrates are affected by the K11R mutation including Clb1 and Pds1/securin most strongly and Clb3, and Clb5 to a lesser extent. The key question that remains to be addressed is whether the effects of the K11R mutation on these substrate levels are direct or indirect. Until the mechanism of the K11R mutation is fleshed out in more detail, one cannot say with any certainty. Since the role of K11 chains is well established for the metazoan APC, this fact lends some support to the notion that the K11 Ub linkage type could play a direct role in APC function in yeast. However, this point also has the effect of subtracting from the novelty of their discovery. The fact that K11R mutant has no effect on WT yeast also suggests that K11 linkages are not all that important to yeast biology.

We thank the reviewer for their interest in the genetic interactions in our study. The reviewer feels that two factors detract from our follow-up analysis of the genetic interaction between K11R and an APC mutant: first, the lack of biochemical corroboration that K11 is used in yeast; second, the fact that K11 has been implicated in human APC biology, which the reviewer feels detracts from the novelty of the story. In addressing the first point, we have done further characterization of the yeast APC in vitro, which we hope the reviewer will agree deepens our mechanistic understanding of the function of K11 linkages. Specifically, we have shown that the APC, in conjunction with the initiating E2 in yeast, Ubc4, adds K11 chains to a model substrate. Thus, we have now shown that K11 is used in vitro, K11 alters APC activity in vivo, and used genetics to show that this alteration has clear biological effects on viability. As for the second point, our analysis shows that the initiating E2 adds short K11 containing chains. The second E2 employed by the APC, Ubc1, has been shown to be K48 specific. This suggests that, while there is an interesting intersection between these systems, the human and yeast APC use K11 in distinct manners. It is important to remember that, while K11 linked chains are important for mammalian APC biology, the E2 that generates them, Ube2S, is not essential in human cells. Similarly, several of the APC subunits themselves can be deleted in yeast, and likely human cells. This does not mean that these proteins are not important, but shows that there is some buffering capacity in the cell for this critical enzyme.

Note: We now include the gnp1∆ data in the supplemental figures.

Additional points:

1) It would be informative if the authors were to show FACS profiles for the analyses described in Figure 4.

We now include FACS cell cycle profiles in Figure 4—figure supplement 1. Importantly, the SK1 strain background is strongly flocculent, making FACS analysis difficult to interpret.

2) The result of the Figure 4B would be more compelling if the authors were to include quantification of band intensities in Figure 4. Also include additional loading controls.

The quantified band intensities for the experiments in Figure 4 are now reported. These are now presented in graphical form and exact half-lives are calculated.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Supplementary file 1. Plasmids used in this study.
    elife-42955-supp1.xlsx (43.4KB, xlsx)
    DOI: 10.7554/eLife.42955.014
    Supplementary file 2. Strains used in this study.
    elife-42955-supp2.xlsx (51.4KB, xlsx)
    DOI: 10.7554/eLife.42955.015
    Supplementary file 3. Oligonucleotides used in this study.
    elife-42955-supp3.xlsx (51.6KB, xlsx)
    DOI: 10.7554/eLife.42955.016
    Supplementary file 4. The full Ubiquitin SGA dataset.
    elife-42955-supp4.xlsx (524.3KB, xlsx)
    DOI: 10.7554/eLife.42955.017
    Supplementary file 5. Quantitative proteomics analysis of the ubiquitinome in doa10Δ, ubc6Δ, ubc7Δ, ubc6,7Δ.
    elife-42955-supp5.xlsx (57MB, xlsx)
    DOI: 10.7554/eLife.42955.018
    Transparent reporting form
    DOI: 10.7554/eLife.42955.019

    Data Availability Statement

    All datasets generated are included as Supplementary Files 4 (SGA dataset) and 5 (quantitative proteomics).


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES